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This work focuses on the integration of microfluidics and dielectrophoresis(DEP) with 
the principles of field flow fractionation (FFF) to create a continuous-flow isolator for 
rare and viable circulating tumor cells (CTCs) from peripheral blood mononuclear cells 
(PBMNs) drawn from cancer patients. The method exploits differences in the plasma 
membrane capacitances of tumor and blood cells, which correspond to differences in the 
membrane surface areas of these cell types. DEP-FFF was first adapted to measure cell 
membrane capacitance, cell density and deformability profiles of cell populations. These 
properties of the NCI-60 panel of cancer cell types, which represents the wide functional 
diversity of cancers from 9 organs and leukemia, were compared with the normal cell 
subpopulations of peripheral blood. In every case, the NCI-60 cells exhibited membrane 
capacitance characteristics that were distinct from blood and, as a result, they could be 
isolated from blood by DEP. The heightened cancer cell membrane capacitances 
correlated strongly with membrane-rich morphological characteristics at their growth 
sites, including cell flattening, dendritic projections, and surface wrinkling. Following 
harvest from culture and maintenance in suspension, cancer cells were found to shed 
cytoplasm and membrane area over time and the suspended cell populations developed 
considerable morphological diversity. The shedding changed the cancer cell DEP 
properties but they could still be isolated from blood cells. A similar shedding process in 
the peripheral blood could account for the surprisingly wide morphological diversity seen 
among circulating cells isolated from clinical specimens. A continuous flow DEP-FFF 
 vii
method was devised to exploit these findings by allowing CTCs to be isolated from the 
nucleated cells of 10 mL clinical blood specimens in 40 minutes, an extremely high 
throughput rate for a microfluidic-based method. Cultured cancer cells could be isolated 
at 70-80% efficiency using this approach and the isolation of CTCs from clinical 
specimens was demonstrated. The results showed that the continuous DEP-FFF method 
delivers unmodified, viable CTCs for analysis, is perhaps universally applicable to 
isolation of CTCs from different cancer types and is independent of surface antigens - 
making it suitable for cells lacking the epithelial markers used in currently accepted CTC 
isolation methods.  
 viii
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Metastatic disease is an often fatal complication that results when cancer spreads 
from a primary tumor and forms one or more new tumors at distant sites in the body.  
The disease is able to migrate in this way when cancer cells become dissociated from the 
primary tumor and are transported through the cardiovascular system as circulating tumor 
cells (CTCs).  If these cells are able to infiltrate surrounding tissues and proliferate, new 
tumors are formed. The consequent disease is termed metastasis of cancer or secondary 
cancer[1, 2]. The presence of CTCs in the peripheral blood of cancer patients has been 
shown to be a prognostic indicator for metastatic disease. Furthermore, the molecular 
profile of the CTCs is expected to be indicative of their invasiveness and capacity for 
uncontrolled proliferation at distal sites in the body[3, 4]. Therefore, the isolation, 
counting and characterization of CTCs are considered to be important capabilities for 
understanding metastatic disease from a research perspective and in prognosis and 
diagnosis in the clinic[2, 3].  However, currently it is a huge technological challenge to 
isolate CTCs because their concentration in the peripheral blood is very small.  For 
example, even one CTC per milliliter of peripheral blood is considered to be indicative of 
a worsening outcome for breast and prostate cancer patients[2, 3]. 
A lot of research effort has been applied to developing novel technologies for 
improved CTC isolation. However, to date, only the CellSearch method, which is based 
on immunomagnetic isolation of EpCAM+ cells in the blood has received FDA approval 
for clinical tests for prognosis[5].  This test is far from ideal because it is only applicable 
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to epithelially-derived tumors that express EpCAM and it cannot collect CTCs from 
tumors that fail to express EpCAM[6, 7]. These include EpCAM negative or hybrid cells 
that are undergoing the epithelial to mesenchymal transition and are considered to be the 
most likely cells to form metastases.  Furthermore, the CellSearch method requires cells 
to be fixed, eliminating the possibilities of characterizing the isolated cells by gene 
expression profiling and conducting growth assays that would permit drug response 
testing for targeted therapies[5], for example. For these reasons, there is great interest in 
the development of technologies that can isolate unaltered, viable CTCs without 
depending on cell surface markers that may be expressed erratically[8]. 
Attempts to develop CTC isolation capabilities with these characteristics have 
included processing blood with microfabricated pore filter arrays and microfluidic 
hydrodynamic capture[9, 10]. The filtering approach assumes that CTCs are significantly 
larger than all of the other cell types present in peripheral blood, an assumption that a 
study of the CTCs collected by the CellSearch method shows to be incorrect. 
Furthermore, although larger CTCs can be captured on microfabricated filters without the 
need to use antibodies to identify them, these cells are damaged and lose viability 
because of the high fluid shear conditions present during filtering[9, 10].  
Microfluidic hydrodynamic capture depends on differences between the inertial 
properties of CTCs and blood cell subpopulations. This method is still under 
development and it is not clear how efficient it will prove to be or whether the isolated 
CTCs will be viable.  
Another method for isolating CTCs from blood without using antibodies is based 
on dielectrophoresis (DEP)[11]. It was shown many years ago that it was possible to trap 
cancer cells on a microelectrode array by applying attractive dielectric forces while blood 
cells were washed away[12, 13]. The cancer cells needed no labeling, remained viable 
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during DEP trapping, and could be released afterwards by turning off the electrical 
signal[12, 14, 15]. A major challenge with that approach has been with scaling. The 
initial experiments on a microchip used only 2000 peripheral blood mononuclear cells 
(PBMNs) containing a few cancer cells[16]. That corresponds to the number of cells in 
only 0.5 µL of peripheral blood. If CTCs, which are clinically significant in 
concentrations as low as one per milliliter, are to be collected, counted and analyzed, the 
minimum clinical specimen size for processing needs to be around 10 milliliters, showing 
that the original DEP method needed to be scaled up by a factor of 20,000 to have clinical 
relevance. Subsequently, DEP was combined with the technique of field-flow 
fractionation (FFF) to create a chromatographic method called DEP-FFF[17, 18]. This 
method, which was shown to successfully isolate unlabeled, viable tumor cells from 
PBMNs even more efficiently than DEP trapping, allowed up to 2 million PBMNs to be 
analyzed in each batch. Notwithstanding this success, the throughput was still 20-fold too 
low for clinical applications[19].  
 
My hypothesis was that the DEP-FFF principles could be adapted to a 
continuous-flow regime that would allow 10 mL clinical specimens to be processed in 
less than 60 minutes and thereby provide a universal and reliable detection method for 
CTCs that was independent of cancer type and surface markers.  
 
This dissertation describes the work I undertook to prove this hypothesis, 
including obtaining a better understanding of the biological basis for DEP isolation of 
CTCs[20], demonstrating the broad applicability of DEP isolation methods to CTCs from 
almost any cancer (Included in the NCI 60 panel are 38 epithelial and 22 non-epithelial 
lines derived primarily from patients with advanced and/or metastatic disease)[21], and 
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designing[22], building and testing a continuous flow DEP-FFF isolation system that had 
the required throughput to process clinical specimens[23].  In the remainder of this 
chapter, the principles of DEP and FFF as applied to manipulating mammalian cells will 
be reviewed[19, 24, 25]. In Chapter 2 these principles will be applied to the problem of 
profiling the biophysical properties of cells that pertain to cell separation by DEP-FFF 
and characterizing the differences between cancer cells and blood cells[24]. Chapters 3 
and 4 detail my investigations into the biological basis for the differences observed 
between blood and cancer cells and shows that cell morphology and plasma membrane 
area at the growth site of the cells are the key defining parameters for these 
differences[20, 24]. In the course of these studies on tumor cells, I observed that they 
tended to undergo morphological remodeling when they were released from their growth 
site and were maintained in suspension for an extended time. The suspended cells shed 
cytoplasm and membrane in the form of giant vesicles in a process that left them smaller, 
but still viable, and that I showed was not related to apoptosis[26], anoikis or 
necrosis[25]. This cell structural remodeling process may account for the surprisingly 
wide range of morphologies that have been observed in CTCs isolated from clinical 
specimens.  Significantly, even though this shedding process modified the cell dielectric 
properties, it did not compromise the ability of DEP to discriminate between blood and 
cancer cells[24].  
An important requirement for any new method for isolating CTCs is that it should 
be applicable to all types of cancer. In Chapter 3, I applied the DEP-FFF method to 
characterize the NCI panel of 60 different cancer cell lines, which represents the wide 
range of tumor functional variants in nine different organs and leukemia[21, 22]. My data 
showed that all types of cancer had characteristics that allowed for their isolation from 
normal peripheral blood under appropriate DEP-FFF settings. Cells from solid tumors 
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had large dielectric differences compared to the normal blood cell subpopulations 
suggesting that CTCs from these tumors can be isolated efficiently from blood. The 
leukemia lines from the NCI-60 panel, however, had much smaller differences compared 
to normal blood cell subpopulations, showing that leukemia cells could be concentrated, 
but not efficiently isolated, from normal blood. Nevertheless, from a clinical perspective, 
the inability to isolate pure leukemia cells from peripheral blood is not a problem. 
Having understood the parameter requirements for efficiently isolating this wide 
range of cancer cell types from solid tumors in the NCI-60 panel, I designed and built a 
continuous-flow DEP-FFF isolator[23].  Chapter 5 describes the technical principles 
involved and shows my final working design, which incorporated a novel method of 
reducing the ionic conductivity of the specimen while simultaneously maintaining its 
osmolarity through a membraneless dialysis method[23]. This allowed the cells in the 
clinical specimens to be maintained under physiological conditions, rather than DEP 
buffer conditions, until they were processed, insuring that their properties did not alter 
during the 40 minutes required to process cells from a 10 mL blood specimen.  After 
membraneless dialysis, the CTCs and blood cells were spatially separated by 
dielectrophoresis and the CTCs were skimmed off.  Using this design, I demonstrate the 
isolation of tumor cell spiked into normal peripheral blood with an efficiency of 70-80% 
and its successful application to clinical specimens[23]. Finally, Chapter 6 draws 





DEP is an electrokinetic phenomenon that has become increasingly popular for 
biological applications in microfluidic and lab-on-chip devices since its introduction by 
Pohl[11, 27]. Gascoyne’s group was instrumental in applying this method for 
characterizing and manipulating cancer cells[19, 25]. His was also the first group to 
demonstrate and exploit negative (repulsive) DEP[19, 25, 28-30], to develop automated 
imaging systems to measure cellular DEP effects and cell dielectric properties, to analyze 
the accuracy of dielectric parameters derived from cell electrokinetic responses, and to 
develop a generalized dielectrophoresis (gDEP) theory that unified the theoretical 
treatments of DEP and traveling wave DEP (twDEP)[31].  In the study of cancer, his 
group was the first to employ AC electrokinetic effects for studying membrane changes 
accompanying differentiation of erythroleukemia, kidney and leukemia cells [32], for 
studying breast cancer and colon cancer; and for correlating changes in membrane 
dielectric properties with membrane structure, morphology and conductivity and with 
[13, 29, 33-35].  As a result, it was possible to separate human leukemic cells and 
human metastatic breast cancer cells from normal human leukocytes through DEP 
migration[12, 36, 37] and DEP retention[12, 29, 38, 39].  
DEP occurs when an inhomogeneous electric field induces dielectric charge 
polarization in a particle and a net force on that polarization arises because the local 
fields acting on the equal and opposite charges on either side of the particle are different. 
The net force, which depends on the dielectric polarizability of the particle in its 
suspending medium, is called the dielectrophoretic force and it can be used to move 
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particles in accordance with their dielectric properties even though the net charge on the 
particle is unaltered and may be zero. Dielectric polarization occurs in both DC and AC 
electric fields, however, DEP manipulations of cells are usually carried out using AC 
fields so that the frequency-dependent dielectric properties of cells and their suspending 
medium can be exploited[18, 19, 24, 25]. 
In a stationary inhomogeneous AC electric field )( fE [40, 41], the DEP force 
acting on a particle can be written as 
 
  ( )( ) 2*3 .Re2 RMSCMsDEP EffRF ∇= πε ,    (1.1) 
 
where  
( ) ( )














=      (1.2) 
 
is the Clausius-Mossotti factor that embodies the complex frequency-dependent dielectric 
properties ( ) ( )fif ppp πσεε 2/* −=  and ( ) ( )fif sss πσεε 2/* −=   of the particle and 
its suspending medium, respectively[11, 40].  f  is the frequency and RMSE  the RMS 
value of the applied electric field and i= 1− .   
The DEP force pushes particles towards strong or weak field regions, depending 
upon whether ( )CMfRe  is positive or negative and thereby allows cells to be attracted or 
repelled from electrode edges.  The electric field inhomogeneity is embodied in the 
2
RMSE∇  term, which reflects the geometry and asymmetry of the electrode configuration 
and the applied AC voltage.   
Note that there is a special value of the frequency of  for which  
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where the DEP force goes to zero and cells in the inhomogeneous electric field will 
experience no DEP movement. At applied AC electric field frequencies below of , the 
DEP force will be negative (repulsive from high electric field regions near electrode 
edges). At applied frequencies above of , the DEP force will be positive (attractive 
towards high field regions near electrode edges).  Substituting for the dielectric and 
conductive components of the complex permittivities and rearranging expression (3) 

























.    (1.4) 
 
Because the direction of the DEP force changes sign at of , this frequency is called the 
DEP crossover frequency[40]. 
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1.3 CELL DIELECTRIC PROPERTIES 
 
The Claussius-Mossotti factor depends on the shape and composition of the 
particle. The most effective dielectric representation for mammalian cells has been shown 
to be the dielectric shell model[41, 42], which approximates the cell as a set of 
concentric, homogeneous spherical shells, with the number of shells increasing as the 
structural complexity of the cell increases.  The number of interfacial dielectric 







Figure 1.1  Single shell model 
The dielectric properties of most mammalian cells are approximated very closely 
by the single shell model (shown above), where an inner sphere of radius r (representing 
the cytoplasm) is surrounded by a thin shell of thickness d (representing the membrane).  
If the membrane has a conductivity that is much lower than the surrounding medium and 
the cytoplasm (consistent with a lipid bilayer membrane having an intact barrier 
function), charges build up at the membrane-medium interface when the cell is placed in 
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an electric field.  The effective permittivity of the cell according to the single shell 





















































εε      (1.5) 
 
where R = r+t  and the subscripts i and mem refer to the cytoplasmic and membrane 
compartments, respectively, as shown in the diagram above. Because the cell membrane 
is very thin we can also write R>>t. Again, each complex permittivity term embodies 
both the real permittivity and real conductivity of each component, 
( ) ( )fif memmemmem πσεε 2/* −=   and  ( ) ( )fif iii πσεε 2/* −= . 
For frequencies between approximately 10 kHz and 1 MHz and an internal 
conductivity >> suspending medium conductivity we can make the approximation that  
[41, 43] 
 
































































*ε .  (1.7) 
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From this expression, we can express the specific capacitance of the plasma 
membrane[41, 43] as 
 





 F.m-2      (1.8) 
 
and the specific conductance of the plasma membrane[41, 43] as 
 






=  S.m-2.     (1.9) 
 
This allows us to rewrite expression (1-4) for the cell crossover frequency in terms of the 
membrane specific capacitance and conductance as 
 






















.  (1.10) 
 
The membrane conductivity for a viable cell having an intact membrane barrier 
function is exceedingly low so that smemGR σ<<. .  Also, membrane capacitance is 
found to be large so that memCR. >> sε .  Therefore, the crossover frequency for intact 












= ,     (1.11) 
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which depends on the suspending medium conductivity sσ .  A cell characteristic that is 






Θ = ,       (1.12) 
 
the cell crossover frequency per unit conductivity of the suspending medium. The 
specific membrane capacitance (the membrane capacitance per unit area) memC  [41]and 


















.       (1.14) 
 
For convenience, the real part of the Claussius-Mossotti factor can also be 
rewritten in terms of the applied AC field frequency f  and the cell crossover frequency 










=         (1.15) 
 
Expression (1.11) shows that there is a direct relationship between the specific 
membrane capacitance and DEP crossover frequency and measurements of DEP 
crossover frequencies may be used to infer cell membrane capacitance.  
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Throughout this dissertation, the DEP crossover frequency will be referred to 
many times because it is a useful descriptor of how particular cell types will behave when 
subjected to DEP manipulation.  Considerable effort is focused in Chapter 2 on 
developing a method to derive distributions of DEP crossover frequencies for cell 
populations. The relationship between DEP crossover frequency and the more 
biologically-relevant cell plasma membrane structure forms the focus of Chapter 4.  
These concepts lead to the subsequent discussions of cancer cell properties and the design 
and implementation of CTC isolators in Chapter 5. 
TheDEP principles shown above have been used in many labs to understand cell 
properties. Different cell types exhibit different DEP properties largely on the basis of 
dissimilarities in crossover frequencies and numerous researchers have demonstrated 
DEP-based isolation of biological cells: stem cells[46], platelets[47], white blood 
cells[48], pancreatic b-cells[49], osteoblasts[50], prostate tumor initiating cells[51], oral 
cancer cells[52, 53], melanoma[54], colorectal cancer cells[55] and circulating tumor 
cells(CTCs) from blood[12, 15, 29, 56, 57]. In many cases, DEP trapping is used as the 
basis for cell separation. In this case, the AC electric field is set to a frequency that is 
above the crossover frequency of a target cell type yet below that of unwanted cells.  
Although Gascoyne’s lab[29, 58] was the first to advocate this approach, its resolution 
proved to be limited because the dielectric differences between the cells need to be large 
if one cell type is to be reliably trapped by positive DEP while the others are reliably 
excluded.  More often, distributions of crossover frequencies for the different cell types 
result in there being a significant subpopulation of target cells that are not reliably 
trapped, resulting in loss of target cells.  For this reason, Gascoyne’s lab and Pethig’s 
lab independently conceived of the method of dielectrophoretic field-flow fractionation 
(DEP-FFF), though the bulk of lab-on-chip work described in the literature today still 
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uses DEP trapping and lacks the finer discrimination needed for clinical applications[19, 
25, 59, 60].   
 
 
1.4 DEP-FFF SEPARATION 
 
 
Figure 1.2 DEP-FFF showing cancer cells attracted and PBMNs levitated 
To allow for higher discrimination in cell isolation applications, Gascoyne’s 
laboratory first introduced a fractionation method termed DEP-FFF[17, 18, 25, 61-63].  
This method uses a large array of thin, parallel interdigitated microelectrodes on the floor 
of the separation device. AC electric fields are applied to these microelectrodes and 
fringing fields are created in the space above them in the separation chamber.  The 
resultant periodic, inhomogeneous electric field pattern is used to create DEP forces on 
cells in the chamber. Depending on the relationship between the applied electric field 
frequency and the DEP crossover frequency, the DEP force on a particular cell type may 
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attract it towards the microelectrode array on the chamber floor or levitate the cell into 
the chamber away from the floor.  The strength and inhomogeneity of the electrical field 
distribution decreases with increasing height above the electrode plane and the DEP force 
on cells falls exponentially with height[19, 25]  If a frequency for which cells 
experience negative DEP is applied to the electrode array, cells will be levitated to a 
height at which the repulsive DEP force balances the sedimentation force.  By equating 
the DEP force and sedimentation force equations and rearranging, the cell equilibrium 

























     (1.16) 
 
where V is the electrical potential applied to the electrode array, A is a geometrical term, 
( )fP  is the proportion of the applied field unscreened by electrode polarization, and 
gsp )( ρρ −  is the sedimentation force per unit volume of the cell[62]. Note that because 
DEP and sedimentation are both body forces, the cell volume cancels and the equilibrium 
height is independent of cell size.  Cells having differences in density and/or dielectric 
properties will therefore be levitated to characteristic equilibrium heights as illustrated in 
Figure 1.2.   
To exploit differences in equilibrium levitation height to bring about cell 
fractionation, fluid flow is initiated in the channel.  Fluid flows through the channel in a 
parabolic profile ranging from zero velocity at the chamber floor and ceiling to maximum 
velocity in the middle (chamber half height). The velocity at height h of this so-called 












hvhvp 16 ,     (1.17)  
 
where H is the chamber height and <v> is the mean fluid velocity.  The cells will be 
carried through the chamber at the flow velocity corresponding to their equilibrium 
levitation height[18, 25].  Mixed cell types starting together as a batch at one end of a 
long chamber will therefore be carried through at different velocities and will be 
separated according to their dielectric and density properties, which dictated their 
levitation heights in the DEP field.  The family of techniques that exploits 
hydrodynamic flow profiles for separation in this manner is termed field-flow 
fractionation (FFF); hence Gascoyne termed this dielectric method DEP-FFF[18, 25].   
 






























Figure 1.3 Separation of breast cancer cells from CD34+ stem cells by DEP-FFF. Cells 
emerging from DEP-FFF were passed directly through a flow cytometry for 
counting and fluorescence typing[63]. 
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As an example of DEP-FFF in action, Figure 1.3 shows the isolation of CD34+ 
hemopoietic stem cells from MDA-MB-43 human breast cancer cells[63]. In this 
example, the CD34+ cells had a much higher crossover frequency (100 kHz) than the 
tumor cells (5 kHz) at the suspension conductivity employed. At the applied DEP 
frequency of  30 kHz, the CD34+ and cancer cells had Claussius-Mossotti factors of -
0.439 and -0.097 , respectively.  As a result, the CD34+ cells were levitated higher, and 
therefore into a faster flowing region of the flow profile, than the cancer cells and eluted 
much quicker.  
Because the velocity gradient of the fluid flow profile (the shear rate) in 
Poisseiulle flow is largest close to the chamber floor, the discriminating power of DEP-
FFF is higher when the cells are levitated less[25].  This occurs in the frequency range 
where the cell DEP force approaches zero[25] close to the crossover frequency. Small 
differences in cell dielectric properties or density then result in significantly different 
transport velocities by the fluid flow. However in this high shear flow region near the 
chamber floor, an additional force called hydrodynamic lift (HDLF) becomes significant 
and this limits how sensitively the levitation height and transport velocity depend on the 
DEP force. In general, the transit time for cells through a DEP-FFF chamber therefore 
depends on the balance of three, rather than two, force components, namely DEP, 
sedimentation and HDLF.  The hydrodynamic lift force on a body depends strongly on 
how deformable the body is in the shear flow, therefore HDLF offers the opportunity to 
probe cell deformability in a contactless manner. Because the HDLF is small at low fluid 
flow rates and in low shear regions well away from the chamber floor or ceiling, and 
large at high flow rates and in high shear regions near the chamber floor, it is possible to 
alter the relative strengths of the DEP and HDLF components by adjusting the 
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experimental conditions[25].  I will exploit this property in Chapter 2 in applying the 
DEP-FFF method to measure cell properties. 
Note that most parameters used in this dissertation are listed in Table 1. 
Table 1.1 Parameters used in Equations 
* parameter value deduced from analysis of dFFF elution measurements 
† The values given pertain to the eluate used in this study comprising an aqueous solution 
of 9.5% sucrose adjusted to a conductivity of 30 mS.m-1 (see Chapter 2) 
 
Symbol  Parameter  Value  Units 
SEDF  Sedimentation force on cell in eluate  *  N 
DEPF  Dielectrophoretic force on cell in eluate  *  N 
HDLF  Hydrodynamic lift force on cell in eluate  *  N 
pρ  Cell Density  *  kg.m‐3 
g Acceleration due to gravity  9.81  m.s‐2 
h  Equilibrium height of cell above DEP array  *  m 
CMf  Claussius‐Mossotti factor  *  — 
0f  Cell crossover frequency  *  Hz 
0Θ  
Cell crossover frequency per unit eluate 
conductivity sf σ/0=  
*  Hz.S‐1 
( )νΦ  Cell deformability factor  *  — 
memε  Dielectric permittivity of cell membrane  *  F.m
‐1 
memC  Cell specific membrane capacitance  *  F.m‐2 
totC  Cell total membranecapacitance  *  F 
memσ  Cell membrane conductivity  *  S.m‐1 
memG  Cell specific membrane conductance  *  S.m
‐2 
iε  Dielectric permittivity of cytoplasm * F.m
‐1 
iσ  Conductivity of cytoplasm  *  S.m
‐1 
R  Cell radius  measured  m 




Table 1.1 (continued) 
V  Applied DEP AC voltage  varies  Volts pk‐pk
f  Applied DEP AC frequency  15 to 300  kHz 
RMSE  Root mean square AC field  varies  V.m‐1 
sρ  Density of eluate  1.036 x 103 †  kg.m‐3 
sσ  Conductivity of eluate  30 †  mS.m‐1 
sε  Dielectric permittivity of eluate  6.90 x 10‐10 †  F.m‐1 
η  Kinematic viscosity of eluate  1.266 x 10‐7 †  m2.s‐1 




s  Microelectrode width and spacing 5.0 x 10‐5  m
d  Microelectrode periodicity  s4=   2.0 x 10‐4  m 
H  DEP chamber height  3.62 x 10‐4  m 
W  DEP chamber width  2.4 x 10‐2  m 
<v> Mean fluid velocity in DEP‐FFF chamber  6.9  mm.s‐1 
( )hv p  Cell velocity in DEP‐FFF chamber at height h Depends on  m.s‐1 
L  DEP chamber Length  0.30  m 
( )fP  Effective proportion of DEP voltage  0.7  — 
ga π34=  π34  x acceleration due to gravity  41.08  m.s‐2 





=  Constant for this study  241.5  m‐1.s‐1 
mixL  Mixing length  Varies  m 
D  Diffusion coefficient  2.5 x 10‐9  m2.s‐1 
inQ  Main inlet flow rate  Varies  mL.min‐1 
inq  Injection flow rate  Varies  µL.min‐1 
outQ  Main outlet flow rate  Varies  mL.min‐1 
outq  Withdrawal flow rate  Varies  µL.min‐1 
inh  Thickness of specimen lamina  Varies  µm 
sh  Skim height    Varies  µm 
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Table 1.1 (continued) 
outd  Withdrawal slot width  127  µm 
sd  Depression distance  Varies  µm 
vW  Vortex diameter  Varies  µm 
S  Mean cell spacing  Varies  ‐ 
N  Particle concentration  Varies  m‐3 
cd  Cell diameter  Varies  µm 
 
 21
CHAPTER 2 MEASUREMENT OF CELL PHYSICAL 




In order to understand the operational requirements for a DEP-activated 
instrument for isolating CTCs efficiently from blood, the first step was to be able to 
measure the properties of blood and tumor cells that would determine their behavior 
under DEP-FFF conditions. Earlier approaches for characterizing the DEP properties of 
cells by conventional DEP and electrorotation methods examined perhaps 20 or so cells 
in each experiment[12, 35, 38, 64-67] and, while this allowed authors to publish mean 
and standard deviations of cell dielectric parameters for a number of different cell types, 
the sampling numbers were too small to provide detailed statistical distributions of the 
cell parameters, especially with regard to cell subpopulations, for example. Furthermore, 
in most published reports, typically only one or two cell types were examined because the 
measurements by conventional methods are so tedious. In order to adequately address the 
design of an isolator that would be widely applicable to different cancer types and be able 
to capture cancer cell subpopulations, a far more detailed analysis, involving much larger 
numbers of cells, was considered to be necessary. Furthermore, this analysis needed to be 
achieved for many different cancer cell types as well as for all the normal blood cell 
subpopulations. To achieve this, a much more versatile and rapid measurement approach 
was required.  
It was realized that the DEP-FFF method might be able to solve this measurement 
problem because the elution profiles from a DEP-FFF device arise from exactly the 
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physical properties of the cells that we need to know to design an efficient isolator. It was 
reasoned that by better understanding the DEP-FFF process, it would be possible to 
derive explicit mappings between the DEP-FFF elution behavior of the cells and the 
required cell physical properties. In this chapter, the cell DEP-FFF elution behavior is 
analyzed theoretically and methods are developed by which such mappings can be 
obtained.  Using these methods, I was able to study the distributions of cell parameters 
of 20,000 to 40,000 cells in each of more than 90 different cell types[24], paving the way 
for a better understanding of the biological basis for the differences between cancer cells 
and normal blood cells (Chapters 3 and 4)[20, 24] and for designing efficient DEP-FFF 
isolators (Chapter 5)[23]. 
 
2.2 METHOD AND MATERIALS 
 
2.2.1 Biophysical parameter determinations by DEP-FFF 
 
As shown in Chapter 1, DEP-FFF employs the principle of positioning cells in a 
hydrodynamic flow profile at equilibrium heights that are determined by a balance of 
DEP, sedimentation and hydrodynamic lift forces (HDLF)[17, 25, 60]. These three forces 
acting on the cells balance when 
 
0=++ HDLDEPSED FFF .     (2.1) 
 
Note that this equation assumes that the cells are freely moving in the 
hydrodynamic flow profile, which carries them through the chamber. In other words, the 
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cells do not come into contact with the chamber floor, an occurrence that would result not 
only in an additional reaction force from the floor but also create poorly-defined steric 
drag between the cells and the floor that would affect their elution times[68]. In order to 
allow the cell parameters to be measured quantitatively, the free suspension condition of 
equation (2.1) was always satisfied except when the DEP force was used to trap the cells 
on the chamber floor (see later). In addition, equation (2.1) assumes that cells do not exert 
forces on one another that perturb their height or motion. Disruptive cell-cell interaction 
forces can include cell dipole-dipole interactions caused by the DEP field and 
hydrodynamic entrainment effects between cells. These forces are negligible if the 
distance between cells is large. For example, Jones[40, 44] showed that dipole-dipole 
interactions are negligible if cells are at least 5 diameters apart. During my DEP-FFF 
experiments, the cell loading concentration easily satisfied these conditions because the 
cells were calculated to have a mean spacing of greater than 100 µm.  
The sedimentation force[25] may be written as  
 
( )gRF spsed ρρπ −⋅= 334 .     (2.2) 
 
For the parallel, interdigitated geometry of the microelectrode array used in my 
studies (having periodicity d), it has been shown that the DEP force at a height h in the 
chamber can be written [17]as 
 








4exp352 ππε .   (2.3) 
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The factor ( ) 10 ≤≤ fP  corrects for voltage drop at the electrode-eluate 
interface due to electrode polarization[61]. The complex polarization impedance at that 
interface can be approximated in terms of an effective polarization resistance polR  and a 
polarization capacitance polC  [61, 69-71] as 
 














+=       (2.4)  
 
The impedance of the bulk suspending[61, 69-71] is  
 









    (2.5)  
 
where bulkR  and bulkC  result from the conductivity ( sσ ) and permittivity ( sε ) of the 
eluate used to suspend cells in the DEP-FFF channel.  For an electrode array comprised 
of plain, parallel, interdigitated electrode elements having equal width and spacing d, the 
“lumped” area of electrode connected to each pole of the signal generator is WL41 and the 
effective spacing of these lumped electrodes is 2d [25], giving 
 






= ,  and     (2.6)  
 




= .     (2.7)  
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The interface and bulk eluate impedances form a voltage divider for the AC signal that is 
applied to the electrode array,  and the proportion of the voltage that acts across the bulk 
the eluate is[25, 61] 
 













bulkRe .   (2.8)  
 
It follows that the voltage drop term ( )fP  may be calculated based on the DEP-
FFF design parameters.  In practice, expression (2.4) for the interfacial impedance 
( )fZ pol  is an approximation that has been shown to depend on the assumption that the 
electrode-solution interface has specific fractal characteristics. Because there was no way 
for me to guarantee that this would be the case for the electrode arrays used in my 
studies, I decided not to rely on this theory. For this reason, a method is developed below 
to measure ( )fP  from the DEP-FFF elution behavior of standard particles[24]. 
Nevertheless, the polarization theory is presented here for the sake of completeness and it 
could prove useful if microelectrode characteristics can be better defined in the future. 
The third force in expression (2.1) is the hydrodynamic lift force. Abkarian et 
al.,[72] through experiments on deformable lipid vesicles, have shown that the HDLF 






0η .      (2.9)   
 
For the parabolic profile of characteristic of Poiseuille flow, which occurs under DEP-




=  where B represents 
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the flow rate through the chamber. The HDLF depends on the initial shape and 
deformability of a cell as expressed by the dimensionless geometry parameter Φ  that 
has a value ranging between zero and 1. Φ indicates the deviation from sphericity of the 
cell under the given flow conditions. If a cell is spherical in the absence of flow, then Φ  
is a measure of how the cell deforms as the flow shear increases. Factors that increase the 
rigidity of a cell are expected to result in smaller values of Φ . 
All of the forces that participate in the force balance of DEP-FFF include the term 
3R  so expression (2.1) can be rearranged and simplified to give the volume-independent 
equation 
 






























πρρ   (2.10) 
 
where 
ga π34=  






In accordance with its physical properties ( pρ , 0f  and Φ ), a cell reaches an 
equilibrium height h  that satisfies equation (2.10).  The cell will be carried through the 
DEP-FFF chamber by the fluid flow at a velocity ( )hvp  corresponding to its equilibrium 
height and it will elute from the chamber of length L in a time ( )hvLT pelution /= .  
Therefore, ( )hvp  can be easily deduced from the elution properties of the cell.  
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The velocity at which particles are carried as a function of height in Poiseuille 
flow has been studied extensively and empirical equations[73] have been given as 
 









=   for h R<< ; 
























hvp   for h R>> . 
 
For the purposes of computing h  from ( )hvp , these two cases can be blended as  
 


























RhRvhvp .   (2.11) 
 
The elution time profiles measured by DEP-FFF can in principle, then, be used to find the 
cell physical parameters, pρ , 0f , and Φ  (and derived parameters) by solving expression 
(2.10) using the value of h  derived from the elution time. However, it is not possible to 
solve for three variables using a single equation and to achieve the desired analysis, it 
was necessary to take advantage of the way in which the DEP and HDLF forces alter 
with height. To do this, I undertook three different measurements on the cell suspensions 
using three different experimental regimes, as follows: 
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2.2.2 Frequency regimes 
 
2.2.2.1 Low frequency regime 
 











= ,  
 
then when f  is much smaller than 0f , its value approaches 21−→CMf . Interestingly, 
this is completely independent of cell properties indicating that all cells will behave 
similarly at low frequencies and will be repelled from strong electric field regions at the 
electrodes by negative DEP.  The strong negative DEP force will levitate cells far from 
the floor (>25μm).  At this height, and at the low flow rates used in my experiments (B= 
4 mL min-1), HDLF  is negligible and it is possible to approximate the force balance 
expression (2.1) as 0=+ DEPSED FF , giving   
 













2   (2.12) 
 
This maps cell elution times (correspondence to the h values via equation (2.11) ) to cell 
densities for given design and operating conditions if ( )fP  is known (see later). Transit 
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times through the chamber for cell suspensions were measured at a DEP frequency of 
f =15 kHz.  
 
2.2.2.2 No DEP regime 
 
When no voltage is applied to the microelectrodes (V=0), the DEP force is zero 
and only sedimentation and HDLF forces occur as the cells flow through the DEP-FFF 
chamber[68, 74]. This regime corresponds to the physical chemistry method called 
sedimentation FFF for which theories have been presented in the literature (Cardot et 
al)[75]. When the flow rate is sufficient, HDLF lifts cells above the chamber floor so that 
they avoid contact with it and steric interactions between the cells and the floor are 
prevented. In this regime, only two forces act on the cells in expression (2.1), namely 
sedimentation and hydrodynamic lift force and 0SED DEPF F+ = [68, 74], giving  
 
( )spB
hac ρρ −⋅=Φ      (2.13) 
 
The cell elution times measured in this mode therefore reflect the cell 
deformability, which controls FHDL, and the cell density, which determines sedimentation.  
Strictly, then, the distribution of the deformability parameter Φ , cannot be obtained 
accurately because our knowledge of the cell density in a no-DEP experiment has to rely 
on a density estimate made from a separate low-frequency DEP-FFF experiment. Most 
fortunately, the cell density distributions found for each of the many cell types I 
examined were all extremely narrow (coefficient of variance <10%).  In contrast, the 
deformability parameter Φ  exhibited a wide range for each cell type (C.V.s were 
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typically >50%).  Because of this, the mean cell density value was used to calculate the 
mappings from elution times toΦ  with the knowledge that the density distribution 
minimally distorted the Φ  profile that was obtained.  As a more formal illustration of 
this point, let us consider two parameters that independently contribute variances v1 and 
v2 to a measured data set. The overall variance will be 22 21 vvveffective += , and for 10% 
and 50% independently contributing variances, the effective combined variance is only 
51%.   
In my experiments, I used flow rates B of 6 and 10 mL min-1 to carry out the 
elution time. Assuming cell density is independent of flow rate, this provided two 
separate estimates of the cell Φ  profiles.   
 
2.2.2.3 Swept frequency regime 
 
When the applied AC DEP frequency is very high, so that , the Clausius-Mossotti 
factor approaches +1 and the resulting large positive DEP force strongly attracts cells to 
the microelectrode array on the chamber floor. Under these conditions, the cells 
experience very strong steric forces and may be trapped completely at the electrode 
edges. I found that cell elution times were several thousand seconds, showing that their 
mean velocity in the chamber was almost negligible compared to 100 to 600 second 
elution times under the 15 kHz and zero DEP regimes, respectively. This observation 
provided a method to investigate the cell crossover frequencies. Cells were loaded into 
the DEP-FFF chamber and subjected to a DEP signal that swept downwards in a 
logarithmic fashion from 300 kHz to 15 kHz over a 600 second period, spanning 
frequencies from well above to well below crossover frequencies for all cell types I 
 31
examined. The DEP force experienced by the cells was initially very high (at 300 kHz) 
and essentially immobilized them but, as the frequency decreased, the positive DEP force 
attenuated and fell towards zero as the frequency approached . As the DEP force fell to 
zero and changed direction to become repulsive, the cells were released from the 
microelectrode array and started to move in the flow stream. Finally as the frequency 
sweep continued downwards below, the cells were repelled by negative DEP force which 
levitated them high above the electrodes into fast moving regions of the flow stream 
where they were transported quickly through the chamber. In this swept-frequency 
regime, the total time taken for cells to exit the chamber reflected how long they had to 
wait before the DEP frequency had swept down to their crossover frequencies, the 
attractive DEP force attenuated, and the cells were levitated. Thus cells having a high 
crossover frequency had to wait less time to be released into the flow stream and be 
eluted than cells having a lower crossover frequency. Thus, the cell elution time was 
indicative of crossover frequency.  
In this case, the complete form of expression (2.10) was used and simulations 
were run using Matlab scripts to calculate elution mappings for cells having different 
crossover frequencies, densities and deformability values. As already indicated, cells 




2.2.3 Iterative Corrections to Cell Parameters 
 
The cell density derivation at low frequency assumes that the DEP frequency is 
much smaller than the cell crossover frequency, f << 0f , so that 21−→CMf .  While 
this condition was found to be easily satisfied for blood cell subpopulations (where, we 
shall see later, 0f  > 100 kHz), I found that some cancer cells had crossover frequencies 
as low as 25 kHz, which is not far above the DEP operating frequency of 15 kHz.  One 
solution would be to lower the DEP frequency but doing so is far from ideal. At very low 
frequencies the electrode polarization factor ( )P f  falls off rapidly, greatly reducing the 
DEP force and the generation of electrochemical species at the microelectrodes also 
increases significantly[17, 61].  For these reasons, when my experiments indicated that 








=   rather 
than 21−=CMf , where 0f  was taken to be the modal value for crossover frequency 
from the 0f  distribution.  The recalculated density value, in turn, was used to obtain a 
revised value of the deformability factor Φ  and together, these two revised values 
provided a revised 0f  distribution. This cycle was continued iteratively and, as long of 
the rate of change of parameters was kept below 5% per iteration, it was found to 
converge on self-consistent values of densities, Φ  values and mean crossover 
frequencies.  For consistency in comparing parameters between cell types, I eventually 
adopted this approach for analyzing all of the DEP-FFF data for different cells.  
Having analyzed the theory of DEP-FFF and devised three operating regimes to 
allow the different cell parameters to be emphasized and estimated from the elution 
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profiles, I next undertook experiments with hollow glass beads, polystyrene beads and 
cells. The cell experiments will be described in Chapters (3) and (4).  
 
2.2.4 Batch-mode DEP-FFF apparatus and methods 
 
To characterize the bead and cell parameters, I used a batch mode chamber for 
DEP-FFF experiments that had been developed prior to my studies. The DEP-FFF flow 
channel was 0.58 mm high x 25 mm wide x 300 mm long and had a floor covered with a 
flex-circuit patterned with interdigitated 50 µm wide gold-on-copper electrodes spaced 
50 µm apart on a Kapton substrate as described in previous publications from the 
Gascoyne laboratory[19, 25, 76] (part of electrode is shown below in Figure 2.1).  3000 
electrode elements ran widthwise across the chamber with alternate elements connected 
to 2 bus lines energized by a signal generator.  This signal generator could deliver 
sinusoidal signals from 1 kHz to 2 MHz and up to 10 V peak to peak at a maximum 
current of 3 A RMS[19, 25, 76] to the microelectrode array. For most experiments, I used 
a 2.8 V peak to peak signal that I monitored with an HP 54601A oscilloscope.  
The batch mode is a typical chromatographic approach in which, a volume of 
particle suspension that is much smaller than the volume of the separation chamber, is 
injected at one end of the chamber with the eluate flow and DEP field turned off. Cells or 
beads were allowed to settle onto the floor of the chamber, a process that was complete 
after 8 minutes of settling time[19, 25, 76]. 
To initiate DEP-FFF after settling, the DEP signal was turned on and eluate was 
delivered by a pulseless gear pump (Ismatec, Glattbrugg, Switzerland) via a 0.2 µm inline 
filter (MediaKap-2, Spectrum Laboratories, Rancho Dominguez, CA). This filter 
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prevented particles from the eluate reservoir interfering with experiments and also 
allowed cells to be processed by DEP-FFF under sterile conditions[19, 25, 76].  
 
 
Figure 2.1 The electrode design for DEP-FFF  
The eluate buffer[19, 25] used in for DEP-FFF experiments was an aqueous 
solution of 9.5% sucrose (S7903, Sigma-Aldich, St Louis, MO), 0.1 mg mL-1 dextrose 
(S73418-1, Fisher, Fair Lawn, NJ), 0.1% pluronic F68 (P1300, Sigma-Fisher, St Louis, 
MO), 0.1% bovine serum albumin (A7906, Sigma-Aldich, St Louis, MO), 1 mM 
phosphate buffer pH 7.0, 0.1 mM CaAcetate, 0.5 mM MgAcetate and 100 units mL-1 
catalase (C30, Sigma-Aldich, St Louis, MO), followed by adjustment to conductivity of 
30 mS m-1 with KCl. For different osmolarity eluate buffers, the sucrose concentration 
was adjusted in a range of 3.7% for 120 mOs and 9.5% for 320 mOs. Pluronic F68 has 
been found to protect cell membranes from flow shear-induced damage in bioreactors and 
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is included to help protect cells during injection to the chamber and flowing out through 
fine PEEK tubing. Dextrose acts as a metabolic source for cells, and catalase has been 
found to protect cells from low levels of electrochemical species, especially reactive 
oxygen intermediates, that can be generated at small concentrations by the 
microelectrodes at low AC field frequencies[19, 22, 25].  
The choice of this buffer was based on many years of DEP studies in the 
Gascoyne laboratory[19, 22, 25]. As indicated earlier, in order to exploit positive as well 
as negative DEP forces, the suspending medium conductivity needs to be much lower 
than the cytoplasmic conductivity. The value of 30 mS was chosen because it is far lower 
than the conductivity of the cytoplasm (~1.2 S.m-1), even if the cells undergo some ionic 
leakage during the experiments, and requires an AC current in my 300 mm long chamber 
of ~2 A RMS. This is not only within the capabilities of the DEP signal amplifier 
employed but also results in only about a 2°C temperature rise as the DEP eluate buffer 
passes through the DEP-FFF chamber. The role of the sucrose is to compensate for 
osmolarity so that cells are not osmotically stressed when they are suspended in the low 
ionic strength eluate. Bovine serum albumin ensures that potentially adhesive surfaces in 
the tubing and separation chamber remain coated with protein and are rendered less 




Figure 2.2 Batch-mode DEP-FFF system[19, 25] 
 
Two different methods were used to analyze cells that eluted from the chamber.  
In one method, the majority of the eluate flow from the upper part of the chamber, which 
did not contains cells or beads, was withdrawn by a syringe pump. The remaining flow 
from the chamber, which contained the cells or beads, flowed out from a port at the 
bottom of the chamber and was collected in timed aliquots by a fraction collector. This 
method is shown in Figure 2.2 above.  In the other method, no withdrawal syringe pump 
was used and all of the flow from the chamber passed through a particle counter. This 
counter (PC2400D, ChemTrac Systems, Norcross, GA) employed light scattering to 
detect particles in eight size interval ranges that could be programmed.  In this way, 
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real-time count and size data could be obtained as the cells or beads eluted. The counter 
was interfaced to a computer with custom software, which plotted individual, size 
resolved elution profiles for the DEP-FFF experiments.  The computer also controlled 
the DEP signal generator signals and the pumps and allowed DEP frequency sweeps to be 
conducted automatically, for example. The custom software also recorded the elution 
data and allowed it to be exported for later analysis by MATLAB scripts or other 
software. 
 
2.2.5 Hollow glass beads 
 
Unfortunately, as explained earlier, one parameter of the DEP-FFF system could 
not be explicitly controlled by design or experimental conditions, namely the electrode 
polarization parameter ( )P f . To take account of this, I conducted DEP-FFF 
experiments using hollow glass beads as density standards that I prepared by isopycnic 
centrifugation separation on a sucrose density gradient[24].  Hollow glass beads (HGB) 
(Cat. 19823-5, Polysciences, Warrington, PA) of heterogeneous densities and in the size 
range of 3 to 20 microns were carefully layered onto a stack of 12 glucose concentrations 
ranging from 50% sucrose at the bottom to 0% sucrose at the top. This stack provided 
density steps in 5% increments from sρ =1230 kg m
-3 at the bottom to sρ =1000 kg m
-3 
on top. The beads and stack were then subjected to centrifugation at 900 g x 45 min. The 
bead fractions that had sedimented into the sucrose layers of different densities were very 
carefully pipetted off layer by layer from top to bottom. The isolated bead fractions were 
washed, suspended in PBS, and used as density standards in low frequency DEP-FFF 
experiments.   
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2.3 RESULTS AND DISCUSSIONS 
 
2.3.1 Density Measurement Results 
 
HGBs exhibit stable and uniform dielectric properties because they have a very 
low dielectric polarizability over an extremely wide range of frequencies. As a result, 
their crossover frequency 0f  is effectively infinite and 0.5CMf = − . Therefore, they 
always experience maximum negative DEP force under DEP-FFF conditions. As shown 
earlier, the particle volume cancels from the DEP-FFF force balance equation. Therefore, 
despite their size heterogeneity, HGBs are excellent calibration particles for DEP-FFF 
purposes.  
The different HGB density fractions were subjected to DEP-FFF, allowing ( )P f  
to be estimated and the mapping from elution time to cell density to be determined for the 
low-frequency DEP regime. The eluting HGBs were measured by the light scatter 
particle counter. Figure 2.3 (A) shows the transfer function to map elution times to 
densities that was derived from the HGB experiments at a DEP operating frequency of 15 
kHz. The shape of the transfer function agrees well with that expected from DEP-FFF 
theory at a value of ( )P f =0.60.  Interestingly, though of no bearing to my study, no 




Figure 2.3 (A) Dependency of the dFFF elution time for hollow glass beads as a 
function of their density difference compared to the eluate buffer.  
theoretical relationship based on eqn (2) and (3) scaled by the best fit of the 
voltage loss parameter (see text). (B) Elution profile for MDA-MB-435 cells 
in an eluate of 250 mOsm at a DEP frequency of 15 kHz (C) Cell density 
distribution profiles for an eluate of 250 mOsm derived by using the 
dependency in A as a mapping for elution profiles like those shown in B. 
(D) Variation of cell density, derived from dFFF, as a function of eluate 
osmolarity. (Red: erythrocytes; Black: PBMNs; blue: MDA-MB-435 for all 
panels) 
 
Once ( )P f  had been determined, it was possible to rapidly profile the density 
of cells and particles. It turned out that DEP-FFF was a very quick method for obtaining 
cell density profiles, requiring less than 5 minutes to profile a specimen.  While the 
methods for obtaining, growing and handling cells will be described in detail in Chapter 
3, some basic ideas of the DEP-FFF transfer function characteristics will be introduced 
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now using some results for normal blood cells (erythrocytes and PBMNs) and cultured 
MDA-MB-231 and  MDA-MB-435 human breast cancer cells.  
The transfer function in Figure 2.3 (A) was used to map elution profiles like that 
shown in Figure 2.3 (B) to the density distributions for erythrocytes, PBMNs and MDA-
MB-435 cells shown in Figure 2.3 (C). The peak density pρ = 1100 kg m
-3 for 
erythrocytes and the peak density with shoulders from pρ = 1055 to 1075 kg m
-3 for 
PBMNs agree very well with results reported in the literatures.  Densities have not been 
reported before for MDA-MB-231 and MDA-MB-435 cells but the profile found, pρ = 
1060 kg m-3 for both MDA-MB-231 and 435 cells, overlaps with the density distribution 
of PBMNs and is consistent with the fact that both PBMNs and those breast cancer lines 
can be collected over a Histopaque 1077 density gradient. 
 One way to test DEP-FFF to see if it detects small changes in cell density is to 
use osmotic effects to manipulate cell volume.  As the osmolarity is altered, cells are 
expected to adjust their cell volumes dynamically by balancing their ion concentrations 
between inside and outside[77]. DEP-FFF allows this dependency of cell densities on 
osmolarity to be investigated. Cells were suspended in eluates of different osmolarities 
ranging from 120 to 320 mOsm. The cell density was then mapped from DEP-FFF 
elution times and the cell density variance was plotted against osmolarity (Figure 2.3 
(D)).  A perfect osmometer will follow the Van’t Hoff equation and show a linear 
dependency of density on osmolarity with a slope of unity. In Figure 2.3 (D), 
erythrocytes showed a slope of 0.69[78], MDA-MB-435 a slope of 0.44, and PBMNs a 
slope of 0.30. These data are consistent with prior measurements in the literature and 
show that erythrocytes are reasonably good osmometers but that PBMNs are not. This is 
because PBMNs have a cell machinery involving ion pumps and chloride channels that 
allows them to adjust to osmotic processes through a mechanism called dynamic volume 
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regulation.  These results show that DEP-FFF can be used to rapidly observe cell 
osmotic responses and dynamic volume regulation.   
 
2.3.2 Hydrodynamic lift 
 
Cells circulating through blood vessels and small capillaries undergo complex 
interactions that determine their transport characteristics that depend on flow rate, vessel 
size and deformation of cell shape[72, 79, 80]. When cells are in vessels that exceed their 
diameter, flow profile and cell deformation provide hydrodynamic lift that determines 
how far they are carried from the vessel walls. When the cells enter microcapillaries 
having a diameter comparable to or smaller than their own then deformability that allows 
them to squeeze through the vessels plays a key role in their migration. The elution times 
measured in the no DEP regime allowed the dimensionless geometry deformability 
parameter Φ  to be determined using the mapping shown in Figure 2.4. I found modal 
values for erythrocytes, PBMNs and MDA-MB-435 cells of Φ =0.04, Φ =0.08 and 
Φ =0.12, respectively, in suspending medium of physiological osmolarity. The geometric 
lift factor increases with deviation from sphericity and greater deformability if they are 
exposed to shear stress, so these results reveal that MDA-MB-435 tumor cells are 
significantly more deformable than PBMNs and especially erythrocytes. Φ  is expected 
to be less when cells have greater membrane rigidity, such as through the membrane 
cytoskeleton of spectrin and actin in erythrocytes or have a well developed bulk 
cytoskeleton of actin filaments and microtubules as in many differentiated cells.  It is 
generally considered that the cytoskeleton is poorly developed and organized in many 




Figure 2.4 Mapping plot between cell elution time and cell deformability[25]. 
 
2.3.3 Total capacitance and cell surface area 
 
The crossover frequency is the most difficult parameter to extract from the force 
balance equation because the DEP force is zero at the crossover frequency and therefore 





























Figure 2.5 (A) Time dependency of the applied DEP field frequency used in the swept 
frequency DEP-FFF regime. (B) Theoretically derived mapping between 
cell elution times in swept regime DEP-FFF and the cell DEP crossover 
frequency for an assumed hydrodynamic lift geometry factor of 0.1 (C) 
Swept frequency regime DEP-FFF elution profiles for erythrocytes (red), 
PBMNs (black) and MDA-MB-435 (blue) at 250 mOsm. (D) The 
distributions of the cell DEP crossover frequencies derived from the elution 
profiles in C using a polynomial fit to the mapping shown in B. 
 
Therefore, the density pρ  and the hydrodynamic lift deformability parameter 
Φ  must be considered when mapping cell elution profiles to DEP crossover frequencies. 
To derive DEP crossover frequencies, the DEP field frequency was swept downwards in 
a logarithmic pattern as shown in Figure 2.5 (A).  Matlab simulations based on the force 
balance equation 2.10 and eluate flow properties in equation 2.11, a mapping surface for 
crossover frequencies versus elution time and density is shown in Figure 2.5 (B) with the 
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assumption that the hydrodynamic lift parameter Φ =0.100. The elution profiles in 
Figure 2.5 (C) then map to the crossover frequency distributions in Figure 2.4 (D).  The 
mean and standard deviations of the crossover frequencies obtained from these profiles 
agree well with the DEP crossover frequency and electrorotation data presented in the 
literature.   
No precedent exists for determining DEP crossover frequency profiles, so there is 
no basis upon which to validate the distributions obtained.  Nevertheless, given the 
requirement to use a single value for Φ  in deriving the transfer function, it is clear that 
the inferred DEP crossover frequency distribution will include broadening caused not 
only by variances in crossover frequency but also by the coefficient of variance of around 
50% in Φ . From a statistical perspective, it is tempting to argue that because the 
observed coefficient of variance in the crossover frequency, including the contribution 
from Φ , is around 50%, the coefficient of variance of the DEP crossover frequencies 
must be much less.  Yet the published data that show standard deviations for DEP 
crossover frequencies that are similar to the standard deviations calculated from my 
inferred crossover frequency distributions argues against this. The only certainty, is that 
the true distributions of crossover frequencies can be no broader than those derived by 
my mapping approach. On that basis, it is possible to assert that a DEP-FFF isolator 
design for cancer cells that can cope with the inferred distribution of crossover 
frequencies will definitely be able to cope with the true distribution of crossover 
frequencies, no matter how narrow it may turn out to be. For this reason, the distributions 




CHAPTER 3 PHYSICAL PROPERTIES OF CANCER CELLS 




In this chapter, the methods developed in Chapter 2 are applied to examine the 
physical properties of different cell types. The overall goal of my research was to develop 
a method to isolate CTCs from clinical specimens using DEP and, if possible, to design a 
DEP-FFF isolator that would be broadly applicable to all types of cancer. In order to 
develop such a broadly applicable design and to predict the optimal cell isolation 
conditions, I therefore examined the cell properties of a wide range of cancer cell types. 
To accomplish this, I selected the NCI-60 panel of cancer cell lines. This panel is made 
up of 60 cell lines recommended for study by the National Cancer Institute that span 
much of the functional diversity for cancers of 9 organ types and of leukemias that are 
seen in clinical practice. I applied the DEP-FFF methods of Chapter 2 to characterize 
these cell lines in order to understand the range of cell properties a cell isolator for CTCs 
is likely to encounter in practice[22]. Because CTC isolation requires exploitation of 
differences between cancer cells and blood cells, I also examined the properties of the 








The NCI-60 panel of cancer cell lines was generously made available to me by 
Dr. Gordon Mills, Director of the Kleberg Center for Molecular Pathways, via the M.D. 
Anderson Cell Line Core Facility.  Over a period of approximately six months, up to 
three cell lines each week were revived from cryogenic storage by the staff of the Core 
facility. Each line was grown according to the conditions specified by the American Type 
Tissue Collection (ATTC) guidelines. The cells were maintained in culture for at least 
two weeks until they reached a stable growth pattern in which they could be passaged 
with a seeding density (depending on doubling time) that led the cultures to reach 50-
70% confluence every 2 to 3 days and provide cell harvests of high viability. This care 
was taken to ensure that the cells were healthy and grown under comparable conditions. 
Cell physical properties are extremely sensitive to stress from overcrowding or media 
exhaustion and it was considered to be important to avoid such problems so that 
comparable DEP data would be obtained for the different cell types. In every case, the 
cell line identity was confirmed by short tandem repeat DNA fingerprinting in the Cell 
Line Core Facility. I am extremely grateful to the staff of the Cell Line Core Facility and 
to Ms. Jamileh Noshrari in our own laboratory for their experience and dedicated work in 
growing these many different cell lines for me.  
Typical culture conditions were as follows: cells were seeded into RPMI (Sigma-
Aldrich) supplemented with 10% fetal bovine serum (FBS) (GIBCO, Grand Island, NY). 
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Once they had reached 50-70% confluence after 2 to 3 days of growth, adherent cell lines 
were harvested by rinsing with calcium- and magnesium-free Hank’s buffered saline 
solution, incubating at 37°C for 5 minutes with Trypsin/EDTA followed by sharp 
tapping, and neutralization with RPMI+10% FBS. Non-adherent cell cultures were spun 
down from culture and suspended directly in RPMI + 10% FBS. Following harvest, the 
cells were counted to ensure >98% viability by trypan blue dye exclusion and they were 
suspended at ~106 cell mL-1 in RPMI + 10% FBS in conical tubes ready for DEP 
analysis.   
Blood was drawn from normal volunteers using 10mL EDTA K2/K3 vacutainers 
(BD, Franklin Lakes, NJ). It was layered onto Histopaque 1077 density medium (Sigma-
Aldrich) and centrifuged at 600g x 30 min. The thin layer of PBMNs were pipette off, 
washed two times, and resuspended in FBS free RPMI.  
 
3.2.2 Dielectrophoretic field-flow fractionation (DEP-FFF) 
 
The DEP-FFF device used in this chapter was the same as that described in 
chapter 2. The microelectrode array was energized with an AC voltage of 2.8 V p-p in the 
frequency range 15 kHz to 300 kHz at currents up to 2.5 A RMS, according to the DEP-
FFF regime.  
The DEP-FFF buffer consisted of an aqueous solution of 9.5% sucrose (S7903, 
Sigma-Aldich, St Louis, MO), 0.1 mg mL-1 dextrose (S73418-1, Fisher, Fair Lawn, NJ), 
0.1% pluronic F68 (P1300, Sigma-Aldich), 0.1% bovine serum albumin (A7906, Sigma-
Aldich), 1 mM phosphate buffer pH 7.0, 0.1 mM Ca acetate, 0.5 mM Mg acetate and 100 
units mL-1 catalase (C30, Sigma-Aldich). The conductivity was adjusted to 30 mS m-1 by 
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adding KCl. This deviated from the DEP buffer used in Chapter 2 by the addition of 
calcium and magnesium, divalent cations that have been shown to stabilize membrane 
integrity[19, 22, 25]. 
As before, the sucrose compensated for the low ionic concentration of the eluate 
buffer, adjusting the osmolarity to the normal physiological of 315 mOs kg-1.  Dextrose 
acted as a metabolic energy source to help maintain cell viability, pluronic played a role 
on an anti-damage surfactant for cells as they flowed near the surfaces of tubing and the 
DEP chamber, bovine serum albumin provided a protective coating on chamber and tube 
surfaces that prevented cell adhesion. Calcium and magnesium stabilized cell membrane 
structure and integrity and catalase provided protection from cell damage by low-level 
H2O2, a byproduct of electrochemical processes when the DEP electrodes were energized 
especially at frequencies below 25 kHz[19, 22, 25]. 
For each DEP-FFF run, a 30µL aliquot of cell suspension (106 cell mL-1) was 
diluted with 300 µL of DEP buffer, and this mixture was injected into the front end of the 
DEP chamber with the eluate flow and DEP field turned off. Cells were allowed to settle 
for 8 minutes. Then, flow of elute buffer was initiated at 4 mL/min and one of three DEP 
signals (see below) was applied to the microelectrode array in order to investigate the 
elution profiles.  For the NCI-60 studies, the cells were counted and sized by laser light 
scatter (PC2400D, ChemTrac Systems, Norcross, GA) as they emerged from the DEP-
FFF chamber. 
To determine the biophysical properties of the various cell types in the NCI-60 
panel, elution profiles were measured for three DEP-FFF conditions to derive the 
parameters contributing to SEDF , DEPF  and HDLF  as explained in Chapter 2, with: 
 
(i) A constant DEP field frequency of 15 kHz; 
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(ii) No DEP field; 
(iii) A logarithmically-swept DEP frequency from 300 kHz to 15 KHz over 600 
seconds.  
 
To derive the cell biophysical parameters from the three cell elution profiles, a 
MATLAB script was used.  The script algorithm first assumed that the mean cell 
crossover frequency was 50of =  kHz and that the mean cell deformability factor was 
1.0=Φ .  The following steps were then iterated until the cell parameters converged on 
self-consistent values: 
(a) The cell elution profile at the fixed frequency of 15 kHz run was mapped 
to differential cell densities ρΔ  for the estimated values of of  and Φ ;  
(b) Based on the mean value of ρΔ  derived from (a), cell elution times for 
the “no DEP” run were mapped to derive the distribution for the cell mechanical 
deformability factor Φ  ; 
(c) Based on the present values of mean ρΔ  and mean Φ  derived from (a) 
and (b), cell elution times for the “swept-frequency” run were mapped to derive the cell 
crossover frequency, of , profile. 
(d) Steps (a), (b) and (c) were iterated until ρΔ , Φ  and of  converged to 
solutions that were consistent with the cell elution profiles observed under all three DEP-
FFF conditions.  
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3.3 RESULTS AND DISCUSSION 
 
3.3.1 Density and DEP crossover frequency distributions 
 
Figure 3.1 shows typical elution profiles under the three different DEP-FFF 
regimes, designated DEP 15 kHz, sedFFF (no DEP signal) and DEP swept, respectively. 
Panels A and B show the differences of these three profiles for SF295 glioblastoma and 
MOLT4 leukemia cell lines, respectively. The profiles clearly show that these cell lines 
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Figure 3.1 DEP-FFF elution profiles for (A) SF295 human glioblastoma cells and (B) 
MOLT4 human acute lymphoblastic leukemia cells demonstrating the 
behavior of NCI-60 cells having differences in their density, dielectric and 
hydrodynamic lift properties.  The elution profiles for 15 kHz DEP reflect 
predominantly cell density differences; those for no DEP (sedFFF) reflect 
cell density and hydrodynamic lift effects; and those using a DEP frequency 
sweep reflect the combination of sedimentation, hydrodynamic lift and DEP 
crossover frequency effects.   
 
At 15 kHz the MOLT 4 cells eluted more slowly than SF 295 showing that the 
DEP force did not levitate the MOLT 4 cells as high as SF 295. This shows that MOLT 4 
cells are denser than SF 295 cells. 
The profiles for the no DEP signal regime show that SF 295 cells elute much 
faster than MOLT 4 cells. Analysis shows that this can mostly be understood just in terms 
of the density difference although SF 295 cells are also slightly more deformable than 
MOLT 4 cells. Finally, the much slower elution profile of SF295 cells than MOLT 4 cells 
under swept frequency DEP-FFF conditions shows that the SF295 cells had to wait much 
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longer in the downward sweeping DEP frequency signal before they were released than 
the MOLT4 cells. This reveals that SF 295 cells had a much lower crossover frequency 
than the MOLT 4 cells.  
Three elution profiles, like those shown in each panel of Figure 3.1, were obtained 
for each of the cell lines in the NCI-60 panel and for several blood cell subpopulations, 
providing the density pρ , crossover frequency of , and cell mechanical deformability 
Φ  parameters for each cell type.  In general, the statistical distributions of the 
parameters, found by mapping the elution profiles into parameter space, were 
asymmetrical and could be approximated by skew-normal statistical distributions. 
Therefore, the cell data for the NCI-60 panel were summarized giving the mean, standard 
deviation, and skew for each derived parameter from the DEP-FFF measurements. To 
represent these data graphically while allowing the extent of overlap of the distributions 
of different cell types to be visualized, Dr. Gascoyne proposed making plots in which the 
symbols took the forms of their skew-normal probability distributions. Data for the cell 
density distributions for the NCI-60 panel of cell lines are shown in Figure 3.2 using this 
representation.  The densities for tumor cell types in the NCI-60 panel ranged from 1048 
to 1068 kg m-3, except for BT-549 (one of five breast cancers) and HOP-62 (one of nine 




Figure 3.2 Densities of the NCI-60 cell types deduced from DEP-FFF analysis of the 
cells and shown in ascending order.  The thickness of each scale bar 
represents the number of cells at a given density relative to the mode, which 
has maximum thickness, based on skew-normal distributions. The blue line 
shows the density of Histopaque 1077 and Lymphocyte Separation Medium 
(LSM) of 1077 kg/m3 
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Jones has shown that cells experience dipole-dipole interactions in an AC electric 
field if they are less than 5 diameters[16, 19] apart and this represents a difficulty for 
CTC isolation because the concentration of erythrocytes in the blood (~4 x 109 mL-1) is 
so high that they are spaced far closer together than 5 diameters. As a result, CTC 
isolation from blood cells by DEP must be preceded by a debulking step in which the 
erythrocytes (approximately 40% of the volume of whole blood) are removed. Once the 
erythrocytes are removed, the cell concentration is dilute enough for DEP isolation to 
proceed without cell-cell interactions.  To remove the erythrocytes, either targeted lysis 
of erythrocytes or centrifugation of the specimen over a density gradient medium 
(histopaque or lymphocyte separation medium (LSM or Ficoll-Hypaque with a density of 
1077 kg m-3) can be used.  The lysis buffer could result in damage to tumor cells if those 
do not possess an adequate dynamic volume response to compensate for osmotic stress. 
This damage might confound proteomic or gene expression analysis of viable tumor 
cells. On the other hand, while centrifugation can eliminate erythrocytes without 
damaging the cancer cells, it is only applicable if the cancer cells exhibit a low enough 
density to be retained on a density gradient while erythrocytes are not. There have been 
arguments in the literature as to whether cancer cells have a density that allows them to 
be retained on Histopaque yet there appear to be no reports of cancer cell density 
distribution measurements. Figure 3.1 resolves this issue entirely by providing, for the 
first time, the cell density distributions for all cancer types in the NCI-60 panel and shows 
that these are all distributed below 1077 kg m-3. This demonstrates that cancer cells will 
be retained without significant loss along with PBMNs through density gradient 
separation of whole blood specimens over standard Histopaque 1077 kg m-3 density 
gradient medium. Therefore, standard density gradient separation is applicable to the 
debulking of erythrocytes without significant loss of tumor cells, assuming that the cell 
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density distributions I observed for the NCI-60 lines are similar to those of CTCs in 
cancer patient blood.  Interestingly, a commercial system is available that purports to 
enable highly efficient isolation of CTCs from PBMNs through centrifugation over a 
density gradient of only 1060 kg m-3[81, 82]. My work does not validate that approach, 
notwithstanding that it is commercially available.  Figure 3.2 clearly shows that while a 
1060 kg m-3 density gradient medium will retain the majority of cells in many types of 
cancers, there are also may types of cancer cells having densities greater than monocytes 
( pρ =1063 kg m
-3) and lymphocytes ( pρ =1071 kg m
-3)[81]. These would be lost by 
centrifugation over a density gradient medium below 1077 kg m-3.  
The DEP crossover frequency data, including that for peripheral blood cell 
populations, derived from my DEP-FFF analysis is shown in Figure 3.3 at an eluate 
conductivity of 30 mS m-1. Significantly, the values of DEP crossover frequencies 
derived for cell types in the NCI-60 panel for which DEP properties are reported in the 
literature agreed well with my findings, showing that the DEP-FFF method provides 
results that are consistent with the established, though painfully tedious, single-cell DEP-
crossover and electrorotation methodologies. The shapes of the symbols used to represent 
the cells in Figure 3.3 again show the skew-normal distributions in the data to facilitate 
simple visualization and comparison among cell types. Figure 3.3 shows that all of the 
peripheral blood cell subpopulations had much higher crossover frequencies than the 
cancer cell types that grew in adherent cultures in the NCI-60 panel. Only three of the 
leukemia cell types in the NCI-60 panel, namely SR, MOLT-4, and CCRF-CEM 
exhibited crossover frequencies that were close to those of any blood cell types 






Figure 3.3  DEP crossover frequencies of the NCI-60 cell types and normal peripheral 
blood cells deduced from DEP-FFF analysis shown in ascending order at a 
suspension conductivity of 30 mS/m. The thickness of each scale bar 
represents the number of cells at a given crossover frequency relative to the 
mode, which has maximum thickness, based on skew-normal distributions. 
The blue line at 65 kHz shows a possible choice for a DEP-FFF operating 
frequency that should be able to isolate NCI-60 cell types, except leukemia 
lines, from normal blood cells.   
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In principle, the DEP force can be used to manipulate, enrich or even isolate cells 
according to the dielectric properties of the cells.  As shown in Chapter 1, mammalian 
cell dielectric properties may be expressed in terms of the cell crossover frequency, 
which indicates the characteristic DEP frequency at which the DEP force is zero as it 
changes direction as the frequency is altered. The fact that different cell lines exhibit 
different crossover frequencies indicates that the cells embody differences in cell 
structure. All tumor types of the NCI-60 panel except for the leukemia-derived lines 
exhibited significantly smaller crossover frequencies than the normal peripheral blood 
cell subpopulations.  However, large differences in crossover frequencies are not 
apparent when comparing cell lines grouped by different organ types.  Thus Figure 3.4, 
which illustrates the crossover frequencies with means and standard deviations for the 
cell lines grouped by organ of origin, reveals differences only between solid organ-
derived, leukemia-derived, and peripheral blood derived cells. It follows that DEP is 
unlikely to be useful for discriminating between solid cancers from different organs.  
Nevertheless, this finding is not disappointing for CTC isolation. On the contrary, 
it means that CTCs from essentially every type of solid tumor will respond to DEP 
similarly. At a DEP frequency of 65 kHz, shown by the blue line in Figures 3.3 and 3.4, 
ALL cancer cells from solid tumors exhibit positive DEP and ALL peripheral blood cell 
subpopulations exhibit negative DEP. This result is quite remarkable, because it suggests 
that a single set of operating conditions can be applied in a DEP-FFF device to isolate 
cancer cells derived from all kinds of solid tumors. If CTCs in clinical specimens have 
dielectric properties that are broadly similar to those of the cell types in the NCI-60 panel, 
it implies that prior knowledge of the cancer type is not required to enable the isolation of 
CTCs; a single set of DEP operating parameters apply to all types of solid tumor CTCs. 
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Clearly, this universality has important implications for the design and application of 
DEP-FFF isolators.  
 
 
Figure 3.4 Range of DEP crossover frequencies ± 1 standard deviation of the NCI-60 
cell types and normal peripheral blood cells deduced from DEP-FFF 
analysis at a suspension conductivity of 30 mS/m by tissue origin.  The 
blue line at 65 kHz shows a possible choice for a DEP-FFF operating 
frequency that would isolate essentially all NCI-60 cell types except 
leukemia lines from blood.   
It is also significant that the blood cell subpopulations exhibited small standard 
deviations in crossover frequencies, ensuring that the crossover frequency distributions of 
the cancer cells are well separated from those of the blood cells. In practice the 
population of PBMNs is much higher than the number of CTCs (10 mL patient blood 
contains ~ 4 x 107 PBMNs having a density below 1077 kg.m-3 and perhaps 0 ~ 200 
CTCs). Only a very tiny overlap in statistical distributions would result in the collection 
of a large number of blood cells and, therefore, very impure CTC isolates.  The large 
gap between the distributions shows that it should be possible to isolate CTCs with high 
purity.  
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The leukemia-derived lines in the NCI-60 panel have crossover frequencies that 
are less clearly distinct than the solid tumor lines from the peripheral blood cell 
subpopulations. At the operating frequency of 65 kHz shown by the blue line in Figures 
3.3 and 3.4, the leukemic cells cannot be isolated as efficiently from the peripheral blood 
cell subpopulations.  Nevertheless, DEP may still be used to concentrate the leukemia 
cells from blood. This agrees with previously published work that showed the enrichment 
of HL-60 leukemia cells from blood cells[38].  
 
3.3.2 Demonstration of the separation of tumor cells from PBMNs 
 
The separation of tumor cells from PBMNs by batch mode DEP-FFF was 
demonstrated in this laboratory before I started my project[19, 25]. However, having 
analyzed the DEP theory in more detail and derived the above findings about differences 
between cancer cells derived from solid tumors and leukemias, it was useful to revisit 
those earlier findings[38]. To do this I chose to spike MDA-MB-231 (breast cancer) and 
HL-60 (promyelocytic leukemia) cells into normal PBMNs in different experiments and 
then to subject these cell mixtures to DEP-FFF separations by batch mode DEP-FFF.  
PBMNs were obtained from normal blood by centrifugation over Histopaque 
1077. MDA-MB-435 and HL-60 cells were cultured as described earlier.  After harvest, 
the cells were incubated for 15 minutes with 5 µg.mL-1 calcein-AM viable cell stain (L-
3224, Molecular Probes, Life Technologies, Eugene, OR) to make them green-
fluorescent for later tracking. Cells were counted and their viability was shown to be 
above 98% by trypan blue dye exclusion.  Approximately 100,000 cancer cells were 
spiked into 106 PBMNs in 1 mL RPMI in each specimen.  
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DEP-FFF was conducted under the same conditions as for the characterization of 
the NCI-60 cells in the previous experiments except that the applied frequency was 
maintained at 65 kHz for the MDA-MB-231/PBMN cell mixture and at 80 kHz for the 
HL-60/PBMN mixture during the runs. The elution profiles obtained for the two 
suspensions are shown in Figure 3.5. 
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Figure 3.5 Batch-mode DEP-FFF elution profiles for two mixtures of cancer cells with 
normal peripheral blood mononuclear cells: (A) Normal PBMNs + MDA-
MB-231 breast tumor cells run at a DEP operating frequency of 65 kHz; (B) 
Normal PBMNs + HL-60 promyelocytic leukemia cells run at 80kHz.  The 
different colors denote cells of differing size ranges detected by the PC2400 
particle counter used to measure cell elution. 
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To allow interpretation of the results, the height at which the different cell types 
traversed the DEP-FFF chamber was calculated from the elution times and is shown 
plotted at the top. Figure 3.5(A) shows the elution profile for the mixture of PBMNs and 
MDA-MB-231 cells at a DEP frequency of 65 kHz. At this frequency, the negative DEP 
force repelled PBMNs between 15 and 30 um above the chamber floor into the fast 
flowing eluate, resulting is a single elution peak that emerged between 180 and 400 
seconds after the run was initiated. MDA-MB-231 cells were eluted much more slowly, 
being pulled by positive DEP towards the microelectrode array on the chamber floor. 
These cancer cells traversed the chamber at equilibrium heights between 6 and 11 um 
above the chamber floor (approximately the cell radius) and eluted between 520 and 1000 
seconds after the run was commenced.  These results meet all expectations of the DEP-
FFF theory based on the observed cell properties.    
Of great significance from the perspective of CTC isolation is that the cell line I 
chose in this experiment, MDA-MB-231 is a so-called triple-negative breast cancer, 
meaning that it does not express estrogen, progesterone or HER-2 receptors. This makes 
it a very difficult cancer to treat from a clinical perspective. Furthermore, this cell line 
does not express the epithelial cell marker EpCAM either. This means that it could not be 
detected by the currently accepted clinical method for CTC analysis, which depends on 
EpCAM for antigen-targeted isolation[83, 84]. DEP-FFF depends on cell structural 
properties and is independent of cell surface antigens. Figure 3.5, then, depicts a 
successful cancer cell isolation from blood cells by DEP-FFF that is not achievable by 
current clinical methods. 
In Figure 3.5 (B), the elution profile is shown for HL-60 cells (promyelocytic 
leukemia cancer) co-suspended with PBMNs at an applied 80 kHz DEP field. This 
frequency was chosen to be midway between the crossover frequencies of HL-60 and 
 62
PBMNs. This frequency levitated lymphocytes to heights between 12 and 25 μm above 
the floor with an elution peak from 250 to 500 seconds after the run started. Other 
mononuclear were eluted even slower, emerging in a broad peak between 300 and 750 
seconds that reflects equilibrium heights of 9 to 20 μm above the floor. The HL-60 cells 
eluated between 730 and 1100 seconds, reflecting equilibrium heights in the DEP-FFF 
chamber of 5.5 to 9 μm above the chamber floor.  
This comparison between elution profiles of cells from a solid cancer and a 
leukemia confirms that the cells from the solid tumor, MDA-MB-231, can be efficiently 
isolated from PBMNs because of the low crossover frequency of the cancer cells. The 
leukemia, HL-60, however, cannot be isolated so efficiently because it has a higher 
crossover frequency.  
 
3.3.3 Cell dielectric differences 
 
In order to understand why cells from solid tumors exhibit consistently lower 
crossover frequencies compared to blood cells, it is crucial to understand the origin of the 
differences in their dielectric properties in biological terms.  As already discussed in 
Chapter 1[41], a mammalian cell that has relaxed to a spherical shape when it is 
suspended in an eluate buffer exhibits a DEP crossover 
frequency ( ) 12o s memf R Cσ π −≈ ⋅ ⋅ ⋅ , where memC is the membrane capacitance per unit 
area of the cell plasma membrane. Clearly, crossover frequency differences might be 
related to differences in either R or memC . Previous studies revealed that memC  plays the 
major role and, from a physics standpoint, differences in membrane composition, 
thickness or area are all possible explanations for these differences in memC . Electron 
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microscopy and biochemistry, however, show that composition and thickness play only a 
minor role in determining memC [35, 85]. Indeed, this lab showed some time ago that it is 
cell plasma membrane area associated with cell surface features including ruffles, folds 
and microvilli that has the most important role in determining cell crossover 
frequencies[24, 41]. To formalize this, we can use the knowledge that the capacitance of 
smooth plasma membrane has a uniform value of 90 ≈C mF m
-2[86]. Surface 
morphology involves folds or crinkles of the membrane of a cell and this increases its 
effective area so that it is larger than it would be for a perfectly smooth membrane by a 
folding factorφ .  In general, 1≥φ , so that the specific capacitance of cells can be 
expressed as 0CCmem φ= . Consequently, the cell crossover frequency can be written 
( ) 102 . .o sf R Cσ π φ −≈ ⋅ ⋅ . The relationship between cell surface capacitance and 
morphology is now well established and this expression, derived by Gascoyne’s 
laboratory some years ago, has become standard in the field.  It follow that the crossover 
frequencies for the NCI-60 and blood cells can be described in terms of their membrane 
folding factors φ . The low crossover frequencies of cancer cells means that they have 
larger folding factors (as well as larger sizes) than blood cells.  Understanding the 




CHAPTER 4 RELATIONSHIP BETWEEN CELL 




The data for the NCI-60 cells obtained in Chapter 3 demonstrated that cancer cell 
lines derived from solid tumors had DEP crossover frequencies that were substantially 
lower than those found for normal subpopulations of peripheral blood cells. Leukemia 
cell lines exhibited crossover frequencies that were intermediate.  Based on the findings 
from earlier studies, it was possible to interpret these results in terms of differences in cell 
surface morphology that led cells to have surface areas that were larger than would be 
expected for perfectly smooth spheres. While it is interesting that the NCI-60 cancer cells 
apparently had consistently greater surface areas than blood cells, it is unreasonable to 
suppose that this would be the case for all types of cancer without discovering a 
biological basis for the finding that could reasonably be extrapolated to other cancer 
types.   
The NCI-60 cell panel includes cell lines that present a wide variety of external 
morphologies in culture and in this chapter, I examine the relationships between the 
morphologies of the different cell types during growth and the subsequent DEP crossover 
frequency properties they exhibited when suspended in eluate buffer after harvest. 
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4.2 METHODS AND MATERIALS 
 
4.2.1 Cell specimens 
 
The NCI-60 cells were grown, and the blood cells were obtained, as described in 
Chapter 3 except that some supplementary experiments were conducted to investigate 
whether trypsinization during harvest affected the subsequent cell dielectric suspensions 
of the cells. To accomplish this, pairs of flasks containing the same cell types were 
grown. One flask of each pair was harvested by trypsinization at 37  for 5 minutes while 
the second was harvested by rinsing twice in calcium-magnesium-free RPMI and 
incubation with 5 mM EGTA for 5 to 10 minutes.  This latter procedure released the 
cells from the culture flasks in large sheets and the cell suspension had to be tapped 
sharply to create a suspension of single cells. While this process was not very efficient, it 
provided enough single cells to compare with the parallel, trypsinized specimen.  
Remarkably, no difference was seen in the DEP-FFF properties of the parallel cultures 
harvested in these two ways.  One by-product of the experiment, however, was the 
opportunity to observe the DEP-FFF behavior of clumps of cells in the un-trypsinized 
specimens.  Small clumps of up to 5 cells showed DEP-FFF properties that were 
consistent with cancer cells, showing that DEP-FFF isolation of clumps of CTCs should 
be as effective as the isolation of individual CTCs.  
 One additional cell type was used in the morphological studies, namely primary 
human ovarian tumor cells that were collected from ascitic fluid that had been withdrawn 
during routine treatment of a patient with stage 3c serous ovarian cancer. This specimen 
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was obtained under an IRB approval protocol (number: LAB07-0108, explained later) 
and with patient consent. The tumor cells were recovered by gently centrifuging the 
ascitic fluid at 600g for 15 min and then resuspending the cell pellet in RPMI medium. 
 
4.2.2 Morphological studies 
 
The morphologies of forty of the NCI-60 cell lines were examined while they 
were growing in culture just prior to being harvested for DEP-FFF experiments. To allow 
comparisons to be made between the cell lines, which were examined in batches of 2 or 3 
per week over a 6 month period, the cultures were photographed under phase contrast 
microscopy.  An example of the variety of cell morphologies observed for the NCI-60 




Figure 4.1 Micrographs showing morphological variations amongst the NCI-60 panel 
of cultured cell lines and illustrating the surface spreading, projections and 
roughness features used as indicators of increased cell surface area 
compared with a perfectly smooth, spherical cell (see later).  MOLT4 (an 
acute lymphoblastic leukemia) shows a spherical exterior morphology with 
little cell flattening, no projections and relatively smooth cell surface 
appearance. This is as close to a smooth, spherical reference cell type of 
minimal surface area as was found in the NCI-60 panel. NCI-H226 (a non-
small cell lung cancer) exhibits cell flattening resulting from cell spreading 
on the surface of the culture flask with projections and membrane surface 
roughness also apparent in some cells. SKMEL28 (a melanoma) 
demonstrates marked dendritic projections with minor flattening and 
occasional cell surface roughness. HCT116 (a colon cancer) shows marked 
surface roughness, with minor flattening and projections. In general, cell 
lines in the NCI-60 panel showed combinations of these gross 
morphological traits that were expected to contribute to increased cell 
surface areas compared with smooth, spherical spheres. 
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My first thought for analyzing the physical appearance of the cells was to apply 
image analysis in order to quantify morphological differences between the cells in the 
photographs of the cultures. However, in consultation with two M.D. Anderson 
professors of pathology (Dr. Frederick Becker and Dr. Savitri Krishnamurthy), two 
cytologists (Ms. Jamileh Noshari and Dr. Katherine Stemke-Hale) and my adviser Dr. 
Peter Gascoyne, it became clear that quantifying not only the diversity of morphological 
complexities of the cells but also taking into account the random degrees of connectivity 
between neighboring cells within each photograph would be far too complex a task for 
available image analysis algorithms.  Instead, these advisers suggested using their 
experience and agreed to independently review the 40 photographs and apply a visual 
scoring system to quantify, by eye, the overall morphological characteristics of each cell 
line.  The scoring system devised for this purpose defined three primary morphological 
characteristics of the cells that were expected to make significant contributions to 
enlarging their cell membrane surface area compared with smooth spherical cells of 
corresponding volume. These attributes were cell flattening and spreading on the bottom 
of the culture flask (designated by a parameter F), cell elongation and dendritic 
projections (designated by a parameter P), and cell membrane surface and peripheral 
roughness associated with small-scale ruffles, folds and microvilli (designated by a 
parameter R). A scoring guide was developed to help quantify the extent to which each of 
these morphological attributes contributed to enhancing total cell membrane area in 
comparison to smooth, spherical cells having the same volume. This guide was 
constructed with the help of MATLAB scripts that generated pictures of “cells” having 
identical volumes but surface areas enhanced by factors of 1.5, 2.0, and 3.0 compared 
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with smooth spheres (see Figure 4.2). Four of the NCI-60 cell lines manifesting these 
features are compared in the photomicrographs in Figure 4.1. 
The five volunteers judged the cell morphologies of the 40 cell photographs 
independently and gave each scores between 1 and 3 for each of the parameters F, P and 
R.  I tabulated these scores and combined them to create an overall membrane area 
morphological factor 
     ( ) 3/RPFM ++= .     (4.1) 
 
Means and standard deviations for the scores of the five volunteers were computed.  
Using this scoring principle, a cell line morphological factor 1=M  indicates a smooth, 
round cell with no spreading or projections while a factor 3=M  defines a highly 
flattened cell with extensive projections and striking surface roughness.  
To examine the human primary ovarian cancer cells obtained from ascitic fluid , 
these cells were spun down onto a slide using a CytoSpin centrifuge and stained with 




Figure 4.2 Simulated cell surfaces showing how exterior morphological differences can 
contribute to an increased cell membrane area compared with the smooth reference 
sphere having identical volume shown at top left.  Cells having surface areas 1.5, 
2.0 and 3.0 times that of the reference sphere are shown. In the left hand panel, the 
effect of cell flattening is illustrated using oblate spheroids as models. The circular 
bodies simulate the appearance of cells viewed from above while the gauge lines 
show how thick the model cells would be if viewed from the side.  In the center 
panel, cells having dendritic projections are modeled as Gaussian probability 
curves that have been rotated in space to create solid bodies. Surface areas and 
volumes can be easily solved explicitly for these shapes. In the right hand panel, 
cell surface roughness is simulated by adding noise at three scale lengths (0.1 x 
radius, 0.4 x radius and 1.6 x radius) to represent microvilli, ruffles and folds on the 
cell surface. These simulations were made in MATLAB using distortions of the 
sphere function and the surface areas were computed by summing the areas of all 
facets on the resulting bodies. 
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4.3 RESULTS AND DISCUSSIONS 
 
The cell density ρ, hydrodynamic deformability parameters Φ  and crossover 
frequency fo inferred from the elution times measured by DEP-FFF for cancer cell lines in 
the NCI-60 panel (described in Chapters 2 and 3) are shown in Table 4.1[24, 25, 87] 
together with the morphological scores for these cells obtained as described above.  
Although it would have been possible also to prepare slides of each blood cell 
subpopulation and score those for morphology also, this seemed redundant in view of the 
beautifully detailed pictures of blood cell subpopulations that are available in the 
literature (a comprehensive atlas of hematology is available online at 
http://www.hematologyatlas.com/principalpage.htm). Therefore, blood cell 
morphological data were scored from those photographs and the blood cell dielectric data 
were referred to earlier publications from this laboratory showing dielectric data 
measured by either electrorotation or by DEP crossover frequency methods (DCO). 
As concluded in Chapter 3, the DEP crossover frequency is related to the cell 
membrane folding factor by the expression 
 
( ) 102 . .o sf R Cσ π φ −≈ ⋅ ⋅ ,     (4.2) 
 
where 90 ≈C mF m
-2 is the capacitance per unit area of smooth lipid bilayer 
membrane[86] and the folding factorφ  takes into account cell surface morphology. 
Given that Chapter 2 shows that DEP-FFF can be used to measure cell crossover 
frequencies, we can use this expression to deduce the membrane folding factor, cell 
specific capacitance, and cell total cell membrane capacitance as  
 
 72
( ) 10212 −≈ CfR os πσφ ,    (4.3)    
0CCmem φ=  and     (4.4) 
12
3
2 −≈ ostot fRC σ .      (4.5) 
 
The values of memC , totC , and φ  derived using these expressions together with cell 
radius, R, are also presented in Table 4.1 for the NCI-60 panel and the subpopulations of 
blood cells. These parameters may be used in conjunction with the morphological data to 
investigate the relationships between cell dielectric and morphological characteristics. 
For example, the total cell capacitance is shown plotted against cell radius in Figure 4.3 
in the form of a log-log relationship. 
 
 
Figure 4.3 Dependency of cell total capacitance on cell radius, R for the NCI-60 and 
blood cell types. 
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Three broad clusters comprising the blood cell types (red), the leukemia cell types 
(yellow), and all other cell types are apparent in Figure 4.3.  Furthermore, although 
considerable scatter is apparent, it is clear from the regression line shown that cell 
capacitance tends to vary with R2.5. This non-integer power is indicative of a fractal 
relationship[24] between cell surface area (proportional to total capacitance) and cell 
volume and stands in contrast to the simple R2 relationship that applies to the surface area 
of smooth spheres of different radius. The existence of fractal relationships between 
biological surfaces and volumes is well known because biological processes occurring 
within the volume of a living body are often dependent on physical phenomena that occur 
at surfaces. For example, the aveoli in the respiratory system, which are responsible for 
gas exchange across membrane surfaces into the volume of the body, consist of highly 
folded surfaces that fill space and exhibit a fractal relationship between area and 
volume[88]. The inference from Figure 4.3 that the surface area of a cell exceeds that 
expected from the simple square law relationship with radius has biological significance 
because it reveals that a long-held paradigm stated in many biological textbooks, which 
states that cell size is capped by limitations to nutritional and metabolite transport 
imposed by a membrane area that can only increase as R2, is incorrect. Rather, it would 
appear that, mediated by surface folding, cell membrane surface area is a biologically-
adjustable parameter. This is further emphasized by the wide range of cell surface areas 
that are observed for a given cell radius. For example, Figure 4.3 shows that cells having 
a radius of ~9 µm exhibit capacitances between 10 and 33pF, representing a 3.3-fold 




Figure 4.4 Cell membrane total capacitance versus cell radius for cell types previously 
reported in this laboratory. The cells symbols are keyed to Table 4.2. 
 
As indicated in Chapter 3, DEP crossover frequency values have been reported in 
the literature for some cell lines that now form part of the NCI-60 panel for which data 
was obtained by single cell crossover and electrorotation measurements(see Table 4.1). 
While the DEP crossover frequency results obtained in my DEP-FFF studies were 
consistent with those prior published crossover frequency results, I felt it was worthwhile 
to collect together all of the earlier DEP data and test whether non square-law behavior 
was also apparent.  These data are shown plotted in Figure 4.4 and once again, the cell 
capacitance values follow a power law trend, this time with a slope of 3.01.  For those 
measurements, then, the cell surface area is found to be essentially proportional to 
volume, again supporting the conclusion that cell size should not be restricted by 
limitations imposed by cell membrane area.   
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The data in Figures 4.3 and 4.4 both clearly imply that the cell membrane folding 
factor increases with cell radius, allowing cell membrane area to increase more rapidly 
than a square law relationship. Figure 4.5 shows the folding factor, calculated from 






Figure 4.5 Cell capacitance data for the NCI-60 and blood cell types expressed as the 
dependency of the plasma membrane folding factor on cell radius R.  Loci 
corresponding to constant DEP crossover frequencies based on Equation 4.3 
are shown. 
 
This clearly illustrates that membrane folding does tend to increase with cell 
radius, and demonstrates that the DEP crossover frequency, which determines the 
behavior of cells in DEP-FFF separation, is determined not by cell radius alone but by an 
inherent cell membrane-folding phenomenon. Figure 4.5 also provides another 
visualization of how membrane area has a broad range for a given cell size (see dashed 
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upper and lower bounds), emphasizing that cell radius is not the sole determinant of cell 
membrane surface area. The figure also shows that blood cells tend to cluster in a region 
of small folding factors while tissues that are associated with solid organs have much 
larger folding factors. This suggests that cell structure-function relationships underlie the 
observed differences in folding factors, giving rise to the idea that the morphology of the 
cell at its site of origin might underlie the DEP crossover frequency phenomenon 
observed once the cells are suspended.  
We can gain insights into such a relationship by considering a cell that is 
embedded at its growth site and has a morphology that is compatible with its local 
environment. In general, a cell that is part of a tissue will have a complicated shape that 
conforms to the cells to which it is attached, and have some membrane area A  and 
some volume V that are consistent with that disposition rather than with the properties of 
a sphere.  
If that cell is released from its tissue of origin either by harvest or by detachment 
during migration, it will lose the anchorages that helped maintain its local conformation 
with other cells at the growth site and the resiliency of its internal cytoskeleton will then 
tend to pull inwards and cause the cell to round up into a sphere as it enters free 
suspension. Assuming the cell remains intact during this release process, the membrane 
and the interior volume of the cell will be conserved. Therefore, we can calculate the 













VR .     (4.6) 
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The membrane area A that previously conformed to neighboring cells will have to be 
accommodated on the surface of the newly rounded cell and, consequently, it will need to 
wrinkle and assume a membrane folding factor given by  
 
( )24/ RA ⋅= πφ .     (4.7) 
 
Combining these expressions, we obtain an expression for the folding factor in 
suspension that arises from the area and volume of the cell at its site of origin  
 
( ) AV ⋅⋅⋅= − 3243 πφ .   (4.8) 
 




















  .  (4.9) 
 
This provides a completely new perspective on the DEP crossover frequency behavior of 
cells in suspension. While previous studies had revealed that the crossover frequency for 
suspended cells is inversely proportional to their total cell surface area, which could be 
correlated with membrane-rich features on the cell surface such as microvilli, ruffles and 
folds, that earlier work gave no clues as to the origin of that morphology. Equations 4.8 
and 4.9, on the other hand, relate these surface features of the cells in suspension to their 
prior history before they entered suspension. The primary assumption of this relationship 
is that cell volume and plasma membrane area are conserved during cell release.  
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Equation 4.9 shows also that the crossover frequency of a cell can be expressed in 
terms of a single morphological length parameter,  . This is the 
radius of a perfectly smooth hypothetical cell that would have the same crossover 
frequency as the “wrinkled” cell under consideration. 
The morphological analysis and DEP crossover frequency data for the NCI-60 
panel of cell types and blood cell subpopulations gives us the opportunity to test these 
relationships.  First, to confirm that cell plasma membrane and the cytoplasmic content 
was indeed conserved during harvest, MDA-MB-231 cells in culture were stained with 
CellMask orange fluorescent plasma membrane stain (C10045, Molecular Probes, Life 
Technologies) and green-fluorescent calcein-AM viable cell stain (L-3224, Molecular 
Probes, Life Technologies). These stains allowed both the cell membrane and the 
cytoplasm to be observed under fluorescent microscopy. When trypsin was added, the 
cell margins of cells in contact retracted from one another and the cells rounded up as 
they then detached from the culture flask. Nevertheless, their plasma membranes relaxed 
onto the rounding cell bodies without fragmentation or loss and the cytoplasmic 
fluorescence was maintained without any apparent leakage from the cell bodies. These 
observations suggested that cell membrane area and cell volume were conserved during 
the release of MDA-MB-231 cells from contact with their neighbors to which they had 
conformed during growth.  
It follows that, for each cell type, the cell membrane folding factor φ  after 
harvest should exhibit a correlation with the M score that quantified its membrane-
impacting morphology prior to harvest.  Figure 4.6 reveals that these parameters do 
indeed correlate. Considering the dependency that had to be placed on human perception 
for obtaining these morphological data and also the assignment of a single value of M to 








this correlation is very strong. It shows clearly that the DEP properties of cells in 
suspension depend on not only the radius of the cells but also their exterior morphology 
at their growth site of origin. 
 
 
Figure 4.6 Cell plasma membrane folding factor φ for the NCI-60 and blood cell types 
plotted as a function of the corresponding membrane morphology factor M. 
 
Figures 4.5 and 4.6 reveal differences between cell types of different origins.  
First, the subpopulations of peripheral blood cells are in the G0 resting phase of the 
growth cycle and are adapted for transportation in free suspension through the circulatory 
system in nutrient-rich plasma through capillary vessels of small size. Morphological 
characteristics including small size and relatively small membrane folding factors are 
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compatible with these functions. Consequently, the peripheral blood cell subpopulations 
(red circles) are grouped closest to the origins of Figures 4.5 and 4.6 and the 
corresponding DEP crossover frequencies are over 100 kHz at the suspending 
conductivity of 30 m S m-1.  
Second, leukemia cells (yellow circles) are also adapted to travelling through 
small capillaries in suspension in the high-nutrient plasma. However, leukemia cells are 
likely not to be in G0 of the cell division cycle and instead exhibit less compact nuclear 
and internal structures. This gives rise to larger cell size and slightly more complex 
surface morphologies than normal blood cells. These features cause them to exhibit 
slightly lower crossover frequencies compared with the normal peripheral blood cells in 
Figures 4.5 and 4.6.  
Finally, solid cancer cell types interact with their neighboring cells and have a 
surface morphology that is adapted to spreading and contact. The membrane areas for 
these cell types reflects the variety of cell morphologies in their native tissues and tumor 
types, ranging from highly transformed to almost normally differentiated tissues. 
Accordingly, Figures 4.5 and 4.6 show that the cell lines from solid cancers exhibit a 
much wider range of morphological complexities than is apparent for the normal blood 
cell subpopulations and leukemia cell types. The larger size and greater membrane 
folding factor of the solid cancer cell types lead them to exhibit cell crossover frequencies 
that are much lower than those of the blood cell subpopulations and leukemias.  
These results are also significant because it has been suggested by Terstappen (the 
inventor of the CellSearch method for CTC isolation by antibodies[6, 8, 89]) that DEP 
approaches are of little value because they merely reflect cell size.  My results clearly 
show that while cell size is one parameter that contributes to cell crossover frequency, 
exterior morphology of the cell membrane is highly important.  For instances, leukemia 
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exhibits a cell total capacitance of 11.7 pF, prostate, ovary and kidney lines near 20 pF, 
and non-small cell lung, breast and central nervous system cancers near 30 pF in spite of 
their similar size of 8.7 m. These dielectric differences are sufficient to isolate these cell 
types from one another by DEP-FFF despite their similar sizes. This is fundamental for 
understanding the power of DEP-FFF that can be expected for CTC isolation in 
comparison to size- and hydrodynamic inertial-filtering of cells[9, 10]. 
 
4.3.1 Stability of DEP properties of cancer cells in suspension: Cell cytoplasmic 
shedding 
 
As shown above, the DEP crossover properties of cells in suspension reflect their 
characteristics prior to release from their site of origin. A fundamental requirement for 
this relationship to hold, however, is that the cell membrane area and cell volume are 
retained during and after the cell release process.  My experiments using membrane and 
cytoplasmic stains showed that this assumption is valid shortly after harvest but it is 
important to remember that cells that are normally attached enter alien conditions when 
they remain in suspension. Indeed, normal cell types typically become so stressed when 
they are removed from their native site that they undergo anoikis[25], programmed cell 
death analogous to apoptosis[26], triggered by loss of signals from their accustomed 
environment. Therefore, the study of CTC isolation would be incomplete without some 
consideration of the how cells from solid tissue behave after they are released from their 
native growth site and are maintained in free suspension for an extended period.  
To examine the behavior of cells that had been grown under adherent conditions 
and were then placed into suspension for an extended period, I harvested MDA-MB-435 
human breast cancer cells by trypsinization and maintained them in a 50 mL centrifuge 
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tube in 10 mL complete media of RPMI+10% FBS for several hours. The tube was kept 
in the incubator at 37  under a 95% air/5% CO2 atmosphere. Approximately once every 
10 minutes, the tube was gently inverted to ensure that the cancer cells remained 
suspended and gas exchange occurred. This procedure contrasts with those of normal cell 
passage, where the cells are harvested, collected in a tube, counted and viability tested, 
and then quickly seeded into a culture flask in a thin layer of medium. In this way, the 
passaged cells normally settle into contact with a new growth surface within about 15 
minutes.  
To examine the cells in longer-term suspension, aliquots were withdrawn at times 
from 15 minutes up to 6 hours following initial harvest. The cells in each aliquot were 
counted, viability was checked, and they were subjected to cell sizing using a Casey cell 
counter/sizer.  Then a cytospin slide was made and this was Wright-Giemsa stained to 
allow microscopic examination of the cell properties. DEP-FFF runs were also conducted 
for cells that had been in suspension for different lengths of time.  The appearance of the 
slides for cells immediately after harvest and two hours later are shown in Figure 4.7. 
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Figure 4.7 (A) Wright-Giemsa stained slide showing the morphology of MDA-MB-435 
cells immediately after harvest. Cell peripheries are rich in lamellipodia and 
blebs and several protrusions of the cytoplasm may be seen detaching. (B) 
After remaining in a suspension in complete tissue culture medium for 2 h, 
the morphology of MDA-MB-435 cells shows the effects of continued 
shedding of cytoplasm. Although most microvesicles are lost during the 
cytocentrifuge slides-making process, a few may be observed between the 
cells in this field. (C) The cytoplasmic shedding results in loss of cytoplasm 
and membrane from the cells. (D) Images of cells illustrating the range of 
cell morphologies found in MDA-MB-435 suspensions following two hours 
in suspension. The cytoplasmic to nuclear ratio (CNR) cover wide ranges as 
they do for circulating tumor cells found in clinical specimens[90]. 
 
Lamellipodia and blebs were clearly apparent on the cells stained immediately 
after harvest but these were seen to reduce in number substantially as time progressed. 
Only two hours after harvest, the cell surfaces were largely devoid of such features. 
Remarkably, the diameter of the cells decreased significantly over the same time. Cell 
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nuclei did not alter in size or appearance.  From these observations, it was immediately 
apparent that the cells were undergoing structural modifications as the result of the 
shedding of cell cytoplasm. The ragged periphery including lamellopodia and blebs of the 
cells gradually encapsulated cytoplasm into extrusions that closed up and detached from 
the cell into the suspending medium in the form of vesicles[91] ranging in size from < 
1μm to 3 μm in diameter.  This process resulted in loss of membrane and cytoplasm 
from the cells, which become steadily smaller with time as is apparent in Figures 4.7(B) 
and (C).  A few of the forming and of the newly shed cytoplasmic vesicles are visible in 
the photomicrographs Figure 4.7(A) and (B).   
Immediately after harvest, cells exhibited a large cytoplasmic to nuclear ratio 
(CNR) and good viability (judged by trypan blue dye exclusion). As the shedding process 
evolved, cells exhibited wider ranges of morphologies and CNRs, as shown in Figure 
4.7(D). Significantly, when seeded into new cultures, these cells still showed good 
regrowth ability despite having shed cytoplasm. Beyond 4 to 6 hours after harvest, 
however, the continuing progress of cytoplasmic loss and resultant reduction in cell size 
(see Figure 4.8) led to some cells with such low CNRs that they exhibited very little 




Figure 4.8 Changing distribution of cell radii as a function of time for MDA-MB-435 
cells kept in suspension. 
 
During the cytoplasmic shedding process, some cells showed visible 
characteristics of apoptosis including an ill-defined, blebbing membrane and a diffuse 
nucleus but most cells did not.  Indeed, the fact that most cells could still be cultured 
even after two hours and a significant loss of membrane and cytoplasm was inconsistent 
with either apoptosis or anoikis being responsible for the remodeling; neither apoptosis 
nor anoikis halt once they have been initiated. Therefore, it appeared that I was observing 
a type of cell remodeling behavior during the first few hours in which the cells were 
adapting to the stresses of detachment by shedding membrane and cytoplasm without 
triggering death mechanisms.  
To confirm that this cell remodeling was distinct from the death mechanisms I 
conducted experiments with 10 mM Blebbistatin, which was added to the cell suspension 
just prior to harvest. This agent acts as an inhibitor of non-muscle myosin (NMM) (which 
is involved in several membrane biomechanical activities, including the formation of 
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blebs and lamellipodia)[92].  Cytoplasmic loss was almost completely inhibited when 
Blebbistatin was present. This showed that the cytoplasmic extrusion and pinch off of 
vesicles that was occurring during cytoplasmic shedding was an active cellular 
physiological process and that contractile forces mediated by NMM were involved.   
Cell suspensions were heterogeneous with respect to cell morphology during the 
shedding process so that a simple time course experiment by DEP-FFF could not be used 
to track cell responses as a function of cell size. Fortunately, the PC2400 particle counter 
used to detect cell elution from the batch mode DEP-FFF instrument allowed cells to be 
resolved by size. Therefore, it was possible to examine the cell suspensions by DEP-FFF 
and obtain elution profiles for the MDA-MB-435 cells that were resolved by cell radius. 
Figure 4.9 shows a log-log plot of cell total capacitance versus cell radius derived in this 
way for six separate DEP-FFF experiments (blue circles). For comparison, the plot also 
shows results for other cell lines from Figure 4.4. The particle counter detected MDA-
MB-435 cells ranging in radius from 10 to 3 µm radius in the shedding mixture, smaller 
than most blood cell subpopulations. Of significance is the dependency observed between 
cell total capacitance and radius. Unlike independent cell types exhibiting a dependency 




Figure 4.9 Dependency of cell total capacitance on cell radius in a heterogeneous 
population of shedding MDA-MB-435 cells (blue circles). Other cell types 
are shown for comparison. 
 
the shedding cells exhibit the dependency 24.1RCtot ∝ . This has profound implications 
for CTC isolation applications because it means that even if a cancer cell has shed so 
much membrane and cytoplasm that it has become as small as a blood cell, its membrane 
capacitance is still so large that it can be easily separated from the normal blood cell 
subpopulations by DEP-FFF.  I repeated these experiments (over 20 times) with MDA-
MB-231 and found almost identical results, showing that this behavior was not unique to 
one type of cancer.   
 At first, it seemed odd that the cell membrane total capacitance would show such 
a strikingly different dependency on cell radius than the independent cell types. However, 
the reason for this difference can again be traced to the prior history of the cell. My 
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results with Blebbistatin showed that the shedding of vesicles was caused by NMM-
induced tension in the membrane. Using the same concepts as LaPlace’s principle of 
surface tension in droplets, the tension needed to bring about the formation of a vesicle 
from the surface of a cell will be proportional to the cell radius and will increase as the 
cell becomes smaller. This means that the residual membrane area surrounding the cell 
will tend to be proportional to the cell radius. This relationship will manifest itself in 
terms of cell dielectric properties as a relationship between total capacitance and cell size 
of 1RCtot ∝ .  This is very close to the observed dependency upon
1.24R , lending 
support to membrane tension-dependent cell cytoplasmic shedding.  
 
4.3.2 Implications for circulating tumor cells 
 
The cell shedding process observed here follows as a cell response to detachment 
and subsequent maintenance in an environment devoid of surface contact. The resulting 
heterogeneity in morphologies that arises is termed pleomorphism and it seems highly 
likely that cancer cells that are shed from tumors and enter suspension in the bloodstream 
will be prone to a similar process of shedding. Indeed, a remarkable pleomorphism is 
found by every method that has been used for CTC isolation including CellSearch, 
microfiltration, flow cytometry, and in my own CTC isolation experiments (see Chapter 
5). One example of pleomorphism in a clinical specimen that may be evidence for cancer 
cell cytoplasmic shedding by cells that have passed from a tumor into free suspension is 
shown in Figure 4.10 for human serous ovarian cancer (the human specimens used in this 
experiment were collected under IRB approved protocols and provided to me without 
patient information or identities. IRB approval protocol number: LAB07-0108, full Title: 
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To characterize a protein expression and activation signature of human ovarian tumors 
using reverse phase protein microarray (RPPA) and to correlate this signature with 
genomic and transcriptional data and patient outcomes, study Chair: Gordon Mills, M.D, 
University of Texas M.D Anderson Cancer Center). The cancer cells collected from 




Figure 4.10 Wright-Giemsa stained slide showing human ovarian cancer cells (larger 
with complex nuclei) obtained from ascitic fluid. The cell peripheries show 
signs of blebbing and protrusions and a range of morphologies having 
widely different cytoplasmic to nuclear ratios is evident just as in the case of 
cultured cells that have stood in suspension for several hours. This suggests 
that an analogous cytoplasmic shedding process may be occurring in these 
cells as a result of their entry into free suspension. 
 
The great significance of my finding that cancer cell capacitance remains high even when 
cancer cells transform into cells having the same size as blood cell subpopulations is that 
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it shows that DEP-FFF should be able to capture even the smallest CTCs similar to 
PBMNs in size. This is certainly not the case for size-based filtering. 
My observations of shedding may also cast light on a puzzling aspect of CTCs, 
namely how such large cancer cells are able to pass into and through microcapillary beds 
and also how they are able to embed and form metastases there. The fact that cancer cells 
can apparently remodel into blood-sized cells without necessarily triggering anoikis or 
apoptosis is highly significant in this regard.  This capability may be a cancer-specific 
trait because normal cells tend to be prone to anoikis and apoptosis while cancer cells 
often have defects in the machinery that triggers these responses. Such defects are often 
cited as mechanisms by which cancer cells resist a variety of environmental challenges, 
including chemotherapy. My results may suggest that these defects may also play a 
significant role in permitting the distant dissemination of tumor cells to form metastases.  
Finally, my results also suggest that caution is needed in drawing inferences about 
native tumor cells from circulating tumor cells. Given that CTCs may have undergone the 
same kind of remodeling observed here for suspended MDA-MB-435 and -231 cells, it is 
important to recognize that the morphological properties of the CTCs, including their 
size, membrane area, and also their total cytoplasmic biomolecular content including 
protein, RNA and µRNAs may be significantly different from their tumor of origin. 
Nevertheless, with this caution in mind, it is clear that important molecular traits 
indicative of mutations and genetic tendencies will remain identifiable in the CTCs. 
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Table 4.1 Dielectric and exterior morphological parameters for the NCI-60 panel 
and blood cells. 
Cell Type Method Tissue Type r,  μm fco, kHz   Cmem, mF.m-2 Ctot, pF  Folding,  φ M=(F+P+R)/3 
Basophils DCO [31] Blood 3.58 ± 0.03 169 ± 18.8 11.2 ± 1.3 1.8 ± 0.2 1.24 ± 0.14 1.38 
B-Lymphocytes  ROT [49] Blood 3.29 ± 0.03 163 ± 45.3 12.6 ± 3.5 1.7 ± 0.5 1.40 ± 0.39 1.25 
 DCO [31]  3.09 ± 0.22 221 ± 17.8 9.9 ± 0.8 1.2 ± 0.1 1.10 ± 0.09  
CD34+ HSC  ROT [50] Blood 3.50 ± 0.05 189 ± 27.8 10.2 ± 1.5 1.6 ± 0.2 1.13 ± 0.17 1.25 
Eosinophils  DCO [31] Blood 4.19 ± 0.07 172 ± 7.3 9.4 ± 0.4 2.1 ± 0.1 1.04 ± 0.04 1.13 
Erythrocytes ROT [51] Blood 3.10 ± 0.02 218 ± 21.8 10 ± 1.0 1.2 ± 0.1 1.11 ± 0.11 1.31 
 DCO [51]  3.10 ± 0.02 185 ± 23.5 11.8 ± 1.5 1.4 ± 0.2 1.31 ± 0.17  
 ROT [14]  2.8 ± 0.1 268 ± 23.8 9 ± 0.8 0.9 ± 0.1 1.00 ± 0.09  
Granulocytes (mixed) ROT [49] Blood 4.71 ± 0.23 130 ± 37.9 11 ± 3.2 3.1 ± 0.9 1.22 ± 0.36   
 DFF  4.70 ± 0.23 95 ± 13.9 15.1 ± 2.2 4.2 ± 0.6 1.68 ± 0.24  
Lymphocytes-
mitototic  
ROT Blood 4.54 ± 0.63 92 ± 17.8 16.1 ± 3.1 4.2 ± 0.8 1.79 ± 0.34 1.80 
Monocytes ROT [49] Blood 4.63 ± 0.36 95 ± 26.8 15.3 ± 4.3 4.1 ± 1.2 1.70 ± 0.48 1.50 
 DCO [31]  4.21 ± 0.05 113 ± 6.4 14.2 ± 0.8 3.2 ± 0.2 1.58 ± 0.09  
Neutrophils DCO [31] Blood 4.06 ± 0.06 170 ± 1.2 9.8 ± 0.1 2.0 ± 0.0 1.09 ± 0.01 1.13 
T-Lymphocytes  ROT [14] Blood 3.5 ± 0.2 176 ± 17.6 11 ± 1.1 1.7 ± 0.2 1.22 ± 0.12 1.38 
 DCO [31]  3.40 ± 0.08 149 ± 20.2 13.3 ± 1.8 1.9 ± 0.3 1.48 ± 0.20  
 ROT [33]  3.04 ± 0.26 184 ± 22.8 12.1 ± 1.5 1.4 ± 0.2 1.34 ± 0.17  
 DFF  3.40 ± 1.29 155 ± 35.2 12.8 ± 2.9 1.9 ± 0.4 1.42 ± 0.32  




Table 4.1 (continued) 
HS 578T DFF Breast 8.88 ± 3.63 40.9 ± 12.4 18.5 ± 5.6 19 ± 5.6 2.05 ± 0.62   
MCF7 DFF Breast 9.08 ± 3.71 33.4 ± 5.4 22.2 ± 3.6 23 ± 3.8 2.46 ± 0.40   
MDA-MB-231/ATTC ROT [14] Breast 6.20 ± 0.58 42 ± 6.8 25.9 ± 4.2 12.5 ± 2.0 2.88 ± 0.47   
 DFF  7.57 ± 2.58 32.3 ± 4.4 27.5 ± 3.7 20 ± 2.7 3.06 ± 0.41   
MDA-MB-435 ROT [50] Breast 7.69 ± 2.92 38 ± 11.8 23 ± 7.1 17.1 ± 5.3 2.56 ± 0.79  
 ROT [14]  7.70 ± 0.72 34 ± 5.5 26 ± 4.2 19.4 ± 3.1 2.89 ± 0.47  
 DFF  7.69 ± 2.92 32 ± 3.7 27.3 ± 3.2 20 ± 2.4 3.03 ± 0.35   
NCI/ADR-RES DFF Breast 8.78 ± 3.28 28.4 ± 3.4 26.9 ± 3.2 26 ± 3.1 2.99 ± 0.36   
SF-268 DFF CNS 7.53 ± 2.77 32.4 ± 7.4 27.5 ± 6.3 20 ± 4.5 3.06 ± 0.70 2.18 
SF-295 DFF CNS 10.02 ± 3.05 28 ± 3.2 24 ± 2.8 30 ± 3.5 2.67 ± 0.31 2.16 
SF-539 DFF CNS 10.45 ± 3.35 25.6 ± 4.1 25.2 ± 4.0 35 ± 5.5 2.8 ± 0.44   
SNB-19 DFF CNS 5.83 ± 2.83 42.2 ± 14.2 27.4 ± 9.2 12 ± 3.9 3.05 ± 1.02   
SNB-75 DFF CNS 8.70 ± 3.20 26 ± 3.4 29.7 ± 3.9 29 ± 3.7 3.3 ± 0.43 2.24 
U251 DFF CNS 7.67 ± 3.12 24.5 ± 4.5 35.8 ± 6.5 27 ± 4.9 3.97 ± 0.73 2.66 
COLO 205 DFF Colon 9.39 ± 3.51 44.1 ± 7.2 16.3 ± 2.7 18 ± 3.0 1.81 ± 0.30   
HCC-2998 DFF Colon 8.45 ± 4.15 52.9 ± 8.8 15.1 ± 2.5 14 ± 2.3 1.67 ± 0.28 1.96 
HCT-116 DFF Colon 8.84 ± 3.97 34.4 ± 6.1 22.1 ± 3.9 22 ± 3.9 2.46 ± 0.44 2.11 
HCT-15 DFF Colon 7.49 ± 3.40 51.6 ± 9.7 17.3 ± 3.2 12 ± 2.3 1.92 ± 0.36 2.08 
HT-29 DFF  Colon 11.66 ± 4.43 45 ± 7.5 12.9 ± 2.2 22 ± 3.7 1.43 ± 0.24   
KM12 DFF Colon 9.52 ± 3.50 43 ± 7.1 16.4 ± 2.7 19 ± 3.1 1.83 ± 0.30   
SW-620 DFF Colon 6.36 ± 2.33 59.4 ± 10.0 17.8 ± 3.0 9.1 ± 1.5 1.98 ± 0.33 1.58 
786-0 DFF Kidney 8.97 ± 3.16 31.7 ± 4.5 23.6 ± 3.3 24 ± 3.4 2.63 ± 0.37 1.91 




Table 4.1 (continued) 
ACHN DFF Kidney 7.58 ± 3.03 32.1 ± 3.8 27.7 ± 3.3 20 ± 2.4 3.07 ± 0.36 2.05 
CAKI-1 DFF Kidney 8.82 ± 3.60 25.2 ± 5.0 30.2 ± 6.0 30 ± 5.9 3.36 ± 0.67 2.53 
RXF 393 DFF Kidney 9.97 ± 3.43 34.1 ± 6.6 19.8 ± 3.8 25 ± 4.8 2.2 ± 0.43 1.82 
SN-12C DFF Kidney 9.64 ± 3.28 34 ± 5.7 20.4 ± 3.4 24 ± 4.0 2.26 ± 0.38   
TK-10 DFF Kidney 8.51 ± 3.06 33.8 ± 3.8 23.3 ± 2.6 21 ± 2.4 2.59 ± 0.29 2.11 
UO-31 DFF Kidney 6.86 ± 1.62 34.1 ± 4.4 28.7 ± 3.7 17 ± 2.2 3.19 ± 0.42 2.31 
CCRF-CEM DFF Leukemia 4.45 ± 1.69 88.2 ± 15.1 17.1 ± 2.9 4.3 ± 0.7 1.9 ± 0.33 1.22 
HL-60 DFF Leukemia 8.42 ± 3.20 69 ± 11.5 11.6 ± 1.9 10.3 ± 1.7 1.29 ± 0.21   
K-562 DFF Leukemia 5.87 ± 2.48 54.9 ± 13.8 20.9 ± 5.2 9.1 ± 2.3 2.32 ± 0.58 1.28 
MOLT-4 DFF Leukemia 5.56 ± 2.07 102 ± 14.7 11.8 ± 1.7 4.6 ± 0.7 1.31 ± 0.19 1.06 
RPMI-8226 DFF Leukemia 7.67 ± 2.85 51.5 ± 12.0 17 ± 4.0 13 ± 2.9 1.89 ± 0.44 1.38 
SR DFF Leukemia 6.81 ± 2.83 79.2 ± 20.5 12.5 ± 3.2 7.3 ± 1.9 1.39 ± 0.36 1.18 
LOX IMVI DFF Melanoma 9.38 ± 3.49 53.2 ± 16.4 13.5 ± 4.2 15 ± 4.6 1.5 ± 0.46 2.13 
M14 DFF Melanoma 7.70 ± 3.22 36.3 ± 4.8 24.1 ± 3.2 18 ± 2.4 2.68 ± 0.35 1.61 
MALME-3M DFF Melanoma 9.29 ± 3.39 31 ± 3.4 23.3 ± 2.5 26 ± 2.8 2.59 ± 0.28 2.19 
SK-MEL-2 DFF Melanoma 8.52 ± 3.20 33.6 ± 4.2 23.5 ± 2.9 22 ± 2.7 2.61 ± 0.32 2.11 
SK-MEL-28 DFF Melanoma 8.82 ± 4.01 29.3 ± 3.5 26.1 ± 3.1 26 ± 3.1 2.9 ± 0.35 2.39 
UACC-257 DFF Melanoma 7.76 ± 3.46 38.7 ± 4.9 22.5 ± 2.8 17 ± 2.1 2.5 ± 0.31   
UACC-62 DFF Melanoma 8.27 ± 3.86 37.8 ± 4.5 21.6 ± 2.6 19 ± 2.2 2.4 ± 0.28 2.33 
A549/ATCC DFF NSCL 9.31 ± 2.99 29.4 ± 3.3 24.6 ± 2.7 27 ± 3.0 2.73 ± 0.30 2.06 
EKVX DFF NSCL 10.74 ± 3.15 30.4 ± 4.2 20.6 ± 2.8 30 ± 4.1 2.29 ± 0.31 1.74 
HOP-62 DFF NSCL 9.84 ± 3.84 33 ± 11.3 20.7 ± 7.1 25 ± 8.7 2.29 ± 0.78 1.97 
HOP-92 DFF NSCL 10.68 ± 3.33 30.8 ± 3.0 20.5 ± 2.0 30 ± 2.9 2.27 ± 0.22 1.86 
NCI-H226 DFF NSCL 8.57 ± 3.58 23.4 ± 3.1 33.6 ± 4.4 31 ± 4.1 3.73 ± 0.49 2.58 
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Table 4.1 (continued) 
NCI-H23 DFF NSCL 8.94 ± 3.41 59.1 ± 18.2 12.8 ± 3.9 13 ± 3.9 1.42 ± 0.44   
NCI-H322M DFF NSCL 9.37 ± 3.12 26.5 ± 5.9 27.1 ± 6.1 30 ± 6.7 3.01 ± 0.67 2.69 
NCI-H460 DFF NSCL 9.85 ± 3.08 38.2 ± 5.4 17.9 ± 2.5 22 ± 3.1 1.99 ± 0.28 1.61 
NCI-H522 DFF NSCL 8.51 ± 3.76 53.4 ± 16.5 14.8 ± 4.6 14 ± 4.2 1.64 ± 0.51 2.27 
IGR-OV1 DFF Ovarian 9.90 ± 3.56 40.4 ± 6.7 16.8 ± 2.8 21 ± 3.5 1.86 ± 0.31 1.61 
OVCAR-3 DFF Ovarian 10.37 ± 3.94 27 ± 4.5 24.1 ± 4.0 33 ± 5.4 2.68 ± 0.45   
OVCAR-4 DFF Ovarian 10.21 ± 3.79 35.6 ± 5.2 18.5 ± 2.7 24 ± 3.6 2.06 ± 0.30 1.72 
OVCAR-5 DFF Ovarian 8.49 ± 3.21 38.3 ± 5.3 20.7 ± 2.8 19 ± 2.6 2.3 ± 0.32 2.32 
OVCAR-8 DFF Ovarian 7.63 ± 3.26 24.1 ± 3.7 36.3 ± 5.6 27 ± 4.2 4.04 ± 0.63 2.71 
SKOV-3 DFF Ovarian 10.41 ± 3.96 33 ± 5.5 19.7 ± 3.3 27 ± 4.5 2.19 ± 0.37   
DU-145 DFF Prostate 8.28 ± 3.01 40.5 ± 5.7 20.1 ± 2.8 17 ± 2.4 2.23 ± 0.31 1.69 
PC-3 DFF Prostate 11.42 ± 4.34 26 ± 4.4 22.4 ± 3.7 37 ± 6.1 2.49 ± 0.42   
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Table 4.2 Total capacitance data for cell types plotted in Figure 4.4 
†Cell total capacitance values were calculated from literature values of cell crossover 
frequencies, f0, or of cited membrane specific capacitances, Cmem. 
 
Cell type Index in Fig 4.4 Radius, R, µm Ctot†, pF Reference
Erythrocytes a 2.8 1.14 32 
B-Lymphocytes  b 3.4 1.44 33,34 
T-Lymphocytes  c 3.4 1.93 33,34 
Basophils  d 3.58 1.80 33 
Neutrophils e 4.06 2.04 33 
Eosinophils  f 4.19 2.07 33 
Monocytes  g 4.21 3.17 33,34 
DS19 HMBA h 5.2 5.20 35 
DS19 unTX i 5.5 6.61 35 
HL-60 j 5.8 7.17 36 
MDA- 231 k 6.2 12.4 14 
6M2 non-perm L 6.4 15. 6 37 
MDA- 468 m 7.2 18.5 Unpub 
HT-29AS15 n 7.62 11.5 Unpub 
HT-29 o 7.75 14.6 Unpub 
MDA-435 p 7.7 22.3 This work
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In the previous chapters,  it was shown that discrimination between cells by DEP 
depends on cell dielectric properties that reflect their morphology and membrane surface 
area[35]. Earlier studies have revealed that unmodified, viable tumor cells can be 
separated from erythrocytes and peripheral blood mononuclear cells (PBMNs) by 
DEP[12, 13, 29], and the method has also been shown to have potential for identifying 
and isolating prostate tumor initiating cells[51], oral cancer cells[52, 53], melanoma[54], 
and colorectal cancer cells[55]. In Chapter 3, these possibilities were taken still further by 
showing DEP is applicable to many types of cancers as evidenced by its ability to 
discriminate between PBMNs and all of the tumor cell types of the NCI-60 panel[93].  
In Chapter 4, the biological basis for this surprising broad capacity to discriminate 
between cancer cells and blood cells was shown to be linked with differences in the 
morphologies of cancer cells in solid tissues in comparison to the blood cells that 
normally reside in suspension in the circulatory system. These morphological differences 
apparently derive from the conformational characteristics of cells at their sites of origin. 
Taken together, these results suggest that DEP should be widely applicable to isolating 
CTCs from blood, regardless of the tissue of origin of the tumor cells. Even more 
surprisingly, the results show that a single set of DEP operating conditions may be 
applied universally for this purpose of isolating CTCs from blood cells, indicating that 
neither knowledge of tumor cell type, nor even the knowledge that a specimen comes 
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from someone with cancer, is a prerequisite for CTC isolation by DEP.  Finally, even 
though I found that cancer cells that were released into suspension appear to undergo 
significant changes in their morphology over a period of a few hours through a process of 
cytoplasmic shedding, these changes do not compromise the ability of DEP to isolate 
those cells from blood. 
To put these findings into practical use in DEP-FFF isolation, it is worthy of note 
that this laboratory laid the groundwork for DEP-based isolation of cancer cells from 
blood in early experiments that showed the differential trapping of tumor versus normal 
cells on small microelectrode arrays[12, 13]. Nevertheless, that approach offered limited 
cell discrimination and very low throughput capacity. To overcome those drawbacks, the 
method of DEP-FFF[94-97] was developed to allow larger batches of cells to be 
processed with higher discrimination. Batch-mode DEP-FFF was shown to achieve 90% 
efficient isolation of cultured breast cancer cells spiked into PBMNs[95] and was also 
able to remove breast tumor cells from CD34+ hemopoietic stem cells with high 
efficiency[98]. While batch mode DEP-FFF is able to achieve good cell discrimination 
and proved to be ideal for characterizing cells in Chapters 3 using the analytical 
approaches developed in Chapter 2, the size of the cell batches that can be processed by 
this method is still limited to around 2 x 106 cells[95].  Because CTCs are present at 
concentrations as low as 1 cell.mL-1 in the peripheral blood, the minimum specimen 
volume considered acceptable for CTC analysis is 7 to 10 mL, a volume that contains ~ 
4x107 PBMNs. To process this many cells for CTC isolation would require 20 batch-
mode DEP-FFF runs, each taking about 15 minutes, and this limitation makes the batch 
mode DEP-FFF technique impractical for use in routine clinical applications.  In this 
chapter, I show how this throughput limitation may be removed through the development 
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of continuous flow DEP-FFF technology that is capable of processing ~6x107 PBMNs 
per hour.  
 
5.2 CONTINUOUS-FLOW DEP-FFF CELL ISOLATION STRATEGY 
 
As shown in Chapter 1, to achieve discrimination between different cell types by 
DEP-FFF, cells must be suspended in a low conductivity medium of physiological 
osmolarity. This low conductivity suspending medium allows both positive and negative 
DEP forces to be exploited.  In addition, the electric current needed to energize the large 
microelectrode array that provides DEP forces is proportional to the conductivity of the 
suspending medium in the DEP-FFF chamber. Use of a low conductivity medium 
reduces the current requirement and lowers the Joule heating in the cell suspension 
medium, which depends on the square of the DEP microelectrode current. For these 
reasons, it is desirable to lower the ionic conductivity of cell specimens prior to DEP 
analysis. Reduction of the ionic concentration, however, leads to a concomitant reduction 
in the osmotic strength of the cell suspending medium and this needs to be compensated 
by the addition of a non-ionic osmolyte so that the cells do not become osmotically 
stressed.  In batch-mode DEP-FFF, ion depletion and osmotic compensation are 
accomplished by mixing a small volume of cells at high concentration with a larger 
volume of sucrose buffer immediately prior to injecting the cells into the chamber and 
then allowing them time to settle to the chamber floor before DEP-FFF analysis begins.   
Unfortunately, the approach of pre-suspending the specimen in a low ionic 
strength buffer with compensated osmolarity is not suitable for continuous flow DEP-
FFF operations. Mammalian cells exhibit changes in their dielectric properties as a result 
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of ionic leakage from the cytoplasm when they are suspended in low conductivity 
medium for more than 103 seconds[95].  This is not a problem in batch-mode DEP-FFF 
where the cells are suspended in the eluate immediately before DEP processing begins 
and the whole process is completed in less than 103 seconds. In continuous flow DEP-
FFF, however, the goal is to process a large specimen gradually using a continuous 
injection approach that takes up to an hour. Suspension of the whole specimen in low 
conductivity medium prior to starting this slow injection process is not feasible if the 
dielectric properties of the cells are to remain unchanged and cell discrimination is to 
remain consistent throughout the process.  Furthermore, to achieve the target throughput 
in the continuous-flow regime, it is not feasible to allow the cells to settle for 8 minutes 
after they have been injected into the separation chamber before instigating the DEP-FFF 
isolation procedure.  
To solve these problems, I developed the continuous flow DEP-FFF approach 
shown in Figure 5.1.  In this scheme, a low conductivity, aqueous sucrose solution 
having physiological osmolarity acts as the eluate in a continuous flow from an inlet port 
(a) to an outlet port (f), establishing a Poisseuille flow profile in the separation channel of 
200 mm length, 25 mm width and 314 μm height.  In the Injection Zone (b), the 
specimen, comprising a cell suspension in physiological medium, is fed through a slot in 
the bottom of the chamber at a continuous flow rate qin, which is much lower than the 
eluate flow rate Qin. Because Qin >> qin, the specimen forms a very thin flow lamina (only 
about 25 µm thick) that travels along the chamber floor under the 290 μm thick flow 
lamina of the eluate. As the thin specimen lamina travels in the Ion-diffusion Region, the 
cells are subjected to sedimentation and weak hydrodynamic lift forces and settle at 
equilibrium heights close to the chamber floor (see Figure 5.1(c)). The sedimentation rate 
of cells in the DEP eluate buffer is between 3 and 15 µm.s-1, depending on cell size and 
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density, so that the maximum time taken for cells to settle down in the 25 µm specimen 








Figure 5.1 DEP-FFF isolation of tumor cells from PBMNs in a continuous-flow 
chamber viewed from the side.  The principles of specimen injection, cell 
settling and specimen deionization, height equilibration by force balance 
and isolation of the tumor cells from PBMNs by skimming are described in 
the text. The relative vertical scale of the extremely thin chamber is 
exaggerated by ~120-fold compared to the horizontal scale to clarity the 
operational characteristics. 
Meanwhile, ions will diffuse from the thin specimen lamina into the eluate flow stream 
above it and, simultaneously, the sucrose will counter-diffuse from the eluate flow stream 
into the thin specimen lamina.  As a result, the high conductivity of the specimen lamina 
is reduced by ion depletion while the osmolarity in the vicinity of the cells is maintained 
at a physiological level by the compensating influx of sucrose.  After flowing a 
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sufficient distance mixL along the chamber for these diffusion effects to reach equilibrium 
(see calculations later), the ion and sucrose concentrations, and the resultant electrical 
conductivity and osmolarity, become independent of height in the chamber and the 
specimen conditions become suitable for DEP separation to be undertaken.   
The flow then enters the DEP Separation Region, where microelectrodes on the 
chamber floor are energized by an appropriate AC voltage to impose DEP forces on the 
cells. The DEP frequency is chosen so that tumor cells are pulled towards the chamber 
floor by positive DEP forces as they flow over the microelectrodes while PBMNs are 
repelled and levitated by negative DEP forces. Cells will move to equilibrium heights at 
which the DEP, sedimentation and hydrodynamic lift forces balance just as in the batch-
mode DEP-FFF process detailed in Chapters 1 and 2 (see Figure 5.1(d)).  Finally, as the 
flow enters the Tumor Cell Skimming Zone (e), fluid is withdrawn through a slot in the 
chamber floor at a rate qout, skimming off a thin lamina of fluid from the bottom of the 
chamber up to a height hs. Tumor cells, which have reached equilibrium heights close to 
the chamber floor, are thereby captured through the withdrawal slot while PBMNs, which 
reached equilibrium heights above the skim height hs, are carried over the slot and exit to 
waste along with the main eluate Qout at (f). The detailed design and operation of these 
stages will be described in more detail in the sections that follow. 
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5.2.1 Continuous injection and skimming 
 
As indicated in the strategy, the aim in the continuous flow DEP-FFF method is to 
transport the specimen along the floor of the separation chamber in a thin lamina that 
flows beneath the main eluate stream. For the parabolic Poiseuille flow velocity profile, 
the thickness of this specimen lamina, hin, above the chamber floor is related to the 
injection flow rate, qin, and the eluate inlet rate Qin according to the expression  
 
( ) ( ) ( )32 /2/3/ HhHhqQQ ininininin −=+ ,    (5.1) 
 
where H is the height of the chamber. For a very thin specimen lamina, qin<< Qin, and  
 
( ) 2/13/ ininin QqHh ≈ .       (5.2) 
 
Analogously, at the withdrawal port, a thin lamina of fluid may be skimmed from the 
chamber floor up to a height hs  by withdrawing fluid at a rate qout, where  
 
( ) 2/13/ outouts QqHh ≈ .      (5.3) 
 
In practice, qin and qout are very small and cell sedimentation can result in 
imperfect injection and skimming behavior if there are either vortices or positions of low 
flow rate at the injection or withdrawal slots.  In order to optimize the slot design, I 
simulated flow profiles for various chamber heights, slot widths and flow rates using 
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COMSOL Multiphysics software (Stockholm, Sweden) assuming that the fluid was 
incompressible and had a density of 1036 kg.m-3 and a dynamic viscosity of 1.31 x 10-3 
Pa.s, reflecting the properties of the eluate medium used for my cell isolation 
experiments. The results for the withdrawal slot simulations are shown in Figure 5.2. The 
behavior at the inlet slot region is a mirror image of that at the withdrawal slot.   
Desirable skimming behavior was observed when the slot width dout was small 
compared with the chamber height H (Figure 5.2 (a)).  In this case, a well defined 
separation region at the slot opening cleanly split the thin lamina of height hs at the 
chamber bottom from the main chamber flow.  Streamlines above the skim height hs 
travelled essentially horizontally across the slot and no regions of low flow rate or 
significant vortices were generated in the separation region.  In this case, tumor cells 
close to the chamber floor would be skimmed cleanly into the withdrawal slot, while 
PBMNs in the fluid above the skim height would be rapidly carried over the slot without 
being thrown into the slot by inertial forces or having the opportunity to sediment into the 





















































Figure 5.2 COMSOL Multiphysics simulations of the fluid flow behavior at the DEP-
FFF chamber withdrawal slot for different geometries and flow rates. (a) 
When the withdrawal slot width dout is small compared with the chamber 
height H, optimum skimming behavior is observed with negligible vortices 
or regions of low flow rate; (b) as the relative withdrawal slot width is 
increased, a vortex forms within the slot, streamlines from the main channel 
are depressed into the slot region, and zones of low flow rate appear; (c) the 
skimming height hs accurately follows that predicted by simple Poiseuille 
flow theory (see text). Vorticity (d) and depression of the streamlines from 
the main channel (e) increase with increasing slot width. 
 
As the withdrawal slot width dout was increased, the separation behavior became 
less ideal (Figure 5. 2 (b)). Although the skim height hs still followed the Poiseuille 
model (equations above), the flow in the slot opening became more complex.  
Streamlines above the skim height hs travelled downwards into the mouth of the slot 
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causing a depression by a distance ds of the region where the withdrawal and main 
chamber flow streams split.  Furthermore, a vortex of diameter Wv formed in the 
withdrawal tube and significant regions of low flow rate were generated in the separation 
region.  In this case, tumor cells close to the chamber floor would be skimmed into the 
withdrawal slot but then potentially recirculated in the vortex. Because of the curvature of 
the streamlines, some may be thrown by inertial forces into the depressed streamlines of 
the main chamber flow, carried back into the main chamber, and lost to waste. 
Meanwhile, PBMNs traveling above the skim height that followed the depressed 
streamlines from the main channel into the chamber mouth would not only have a 
tendency to be thrown into the withdrawal flow by the curvature of the streamlines but 
also would need to be carried uphill from their depressed locations well down inside the 
mouth of the withdrawal slot back into the main chamber against the sedimentation 
forces acting on them. As a result of these effects, some PBMNs would enter the 
withdrawal stream and contaminate the tumor cell fraction.   
My simulations established criteria for designing efficient withdrawal slots and 
they showed, in particular, that a withdrawal slot of width dout < H/3, regardless of the 
flow rate, exhibits negligible depression of the main chamber streamlines into the mouth 
of the withdrawal port (Figure 5.2 (e)) as well as providing low vorticity (Figure 5.2 (d)). 
Exactly analogous principles apply to the injection slot design if the potential for cell 
accumulation in the mouth of the injection slot is to be reduced. In my experiments, I 
used a chamber height of 314 μm and injection and withdrawal slot widths of 127 μm, 
corresponding to the flow conditions shown in Figue 5.2 (a). At the inlet, the specimen 
was injected at a rate of qin=25 μL.min-1 with a main eluate flow rate Qin=1000 μL.min-1, 
leading to a specimen lamina thickness hin=29.3 μm at the inlet. At the outlet, the 
withdrawal rate was qout=20 μL.min-1 leading to a skimming height of hs=26.4 μm. In my 
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experiments, the injection and withdrawal flows were provided by 1 mL syringes driven 
by digital syringe pumps (KDS210, KD Scientific, Holliston, Massachusetts) and the 
eluate flow was provided by a precision gear pump (Ismatec, Glattbrugg, Switzerland). 
The concept of combining and splitting lamina flow streams in a microfluidic 
channel is the basis of the so-called H filter design in which two inlet ports enter from 
opposite sides at one end of the chamber to combine lamina flows and two withdrawal 
ports exit from opposite sides at the other end of the chamber to split lamina flows[99].  
In cell separation applications, sedimentation of cells is a significant problem at low flow 
rates and the channels and tubing that carry the cells into and out of the separation 
chamber should be oriented vertically to avoid cell loss resulting from settling and 
adherence to tubing surfaces. In the H-filter design[99], regions of stagnant flow can 
occur at both ends of the chamber at the interfaces of the flow streams.  At the low flow 
velocities required for isolation of tumor cells, sedimentation of PBMNs would occur in 
the slow-moving region of fluid heading towards the top withdrawal port in the H-filter 
configuration and some PBMNs would inevitably fall into the lower withdrawal port and 
contaminate the tumor cell isolate.  For these reasons, I adopted the π configuration for 
my continuous flow DEP-FFF chamber, thereby eliminating stagnant flow in the fluid 
interface regions and greatly reducing the possibility of contamination.  In my design, 
tumor cells flow directly downward through the withdrawal slot in the chamber floor 
while PBMNs travel horizontally. Furthermore, microelectrodes are positioned on the 
chamber floor on both the upstream the downstream sides of the withdrawal slot in my 
design. These electrodes continue to levitate PBMNs by DEP forces in the slot region and 
on the far side of the slot. This helps reduce still further the likelihood PBMNs will fall 
into the withdrawal slot and contaminate the tumor cell isolate.  In these ways, my 
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chosen π configuration improves significantly upon the H-filter design concept for 
applications involving sedimentary particles such as cells. 
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5.2.3 Deionization and osmotic compensation 
 
In order to pull tumor cells towards the microelectrodes on the floor of the 
separation chamber by positive DEP while simultaneously repelling PBMNs high into the 
eluate flow stream by negative DEP, as required by the continuous-flow DEP-FFF cell 
isolation strategy, the cell suspending medium conductivity must be much lower than the 
cell cytoplasmic conductivity[100]. After collection, my specimens were in physiological 
medium containing approximately 150 mM NaCl and having a conductivity of 1.4 S.m-1. 
This suspending medium conductivity was  approximately the same as that of the cell 
cytoplasms, and needed to be lowered to a target value of about 60 mS.m-1 before the 
cells could be subjected to DEP separation.  This reduction in conductivity was 
accomplished by using diffusion to deplete the ions in the specimen as it moved through 
the Cell Settling and Ion Diffusion Zone shown in Figure 5.1 (c). The length of the Ion 
Diffusion Zone was chosen in accordance with the chamber height H and flow rate Qin to 
insure that ions had sufficient time to diffuse throughout the chamber height before the 
sample entered the DEP zone.  The required mixing length Lmix for a diffusible species 
to approach equilibrium has been analyzed for the H-filter microfluidic 
configuration[101] and, by analogy for my π configuration device, may be written as  
 
( ) ( )WDqQHL ininmix /+≈ ,     (5.4) 
 
where W is the width of the chamber in the direction perpendicular to the plane of Figure 
1 and D is the diffusion coefficient of the diffusing species.   
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My cell specimens contained between 20 x 106 and 40 x 106 PBMNs (along with 
trace levels of tumor cells) collected from whole blood by centrifugation over Histopaque 
1077 (Cat 10771-100mL, Sigma-Aldrich, St Louis, USA) and were suspended in 1 mL 
RPMI medium that had been adjusted to a density of 1036 kg.m-3 by adding iodixanol 
(OptiprepTM Density Medium D1556, Sigma-Aldrich, St Louis) to a concentration of 
11%[95]. I used the same eluate recipe as in earlier DEP-FFF studies[24, 95]  and the 
work in Chapters 2-4. This was composed of an aqueous solution of 9.5% sucrose 
(S7903, Sigma-Aldich, St Louis, MO), 0.1 mg mL-1 dextrose (S73418-1, Fisher, Fair 
Lawn, NJ), 0.1% pluronic F68 (P1300, Sigma-Aldich, St Louis, MO), 0.1% bovine serum 
albumin (A7906, Sigma-Aldich, St Louis, MO), 1 mM phosphate buffer pH 7.0, 0.1 mM 
CaAcetate, 0.5 mM MgAcetate and 100 units mL-1 catalase (C30, SigmaAldich, St Louis, 
MO).  This mixture was adjusted to a conductivity of 30 mS m-1 with KCl.  As before, 
in this mixture Pluronic F-68 provided mechanical stabilization of cell membranes under 
flow conditions[102], catalase protected cells from reactive oxygen intermediates[103], 
and bovine serum albumin inhibited cell adhesion to tubing and chamber surfaces.  The 
specimen and eluate densities were both 1036 kg.m-3, as a result of their iodixanol and 
sucrose contents, respectively, and this parity of densities was chosen to avoid the 
possibility of convection mixing occurring when the specimen and eluate flow streams 
were combined in the continuous flow chamber.  
After the specimen was injected into the chamber, the Na+, K+ and Cl- ions that 
dominated its high conductivity diffused into the eluate. Sucrose counter diffused from 
the eluate to maintain the osmolarity of the cells at a physiological level so they were not 










Figure 5.3 COMSOL-multiphysics simulations of the conductivity distribution in the 
flow stream (a) at the specimen injection zone, (b) at the midpoint of the cell 
settling and ion diffusion zone, and (c) at the cell skimming zone. 
 
To investigate the diffusion process and select flow rates that were slow enough for them 
to approach equilibrium throughout the height of the DEP-FFF chamber, I simulated the 
diffusion of ions and sucrose in the continuous flow device using COMSOL Multiphysics 
software. The results for the conductivity distributions in key zones of the chamber are 
shown in Figure 5.3. In the specimen injection zone (Figure 5.3 (a)), a very large 
conductivity gradient exists where the specimen stream (1400 mS.m-1) first joins the 
main eluate flow (30 mS.m-1). At a distance 18 mm downstream from the specimen inlet, 
in the cell settling and ion diffusion zone (Figure 5.3 (b)), the ion conductivity is clearly 
spreading upwards through the chamber. By the time the flow reaches the DEP 
equilibration zone 40mm downstream from the specimen inlet and the tumor cell 
skimming zone 80mm downstream from the specimen inlet (Figure 5.3 (c)), ion diffusion 
is essentially complete and the conductivity is homogeneous throughout the chamber 
height at about 61.5 mS. m-1.  I showed, similarly, that sucrose diffusion is also 
completed before the specimen reaches the DEP equilibration zone.   
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To verify these simulation results, I measured the AC current drawn by the 
microelectrode array. This depends much more sensitively on the conductivity of the 
medium immediately adjacent to the microelectrode than on the conductivity higher in 
the chamber. I found that the microelectrode current was the same under continuous 
specimen injection conditions as when the chamber was filled with a homogeneous 
medium having a conductivity of 61.5 mS.m-1 (the equilibrium conductivity for the flow 
steams in the DEP-FFF chamber). This showed that diffusion was complete and the ion 
concentration had reached equilibrium.  I also conducted an experiment in which fluid 
leaving the ion diffusion region was skimmed from the chamber floor up to different 
heights by altering the withdrawal flow rate.  The conductivity of the withdrawn fluid 
was 61.5 mS.m-1 regardless of the skim height, again showing that diffusion was 
complete.   
This method of reducing the conductivity during flow through the ion diffusion 
zone insured that all cells were subjected to exposure to low conductivity conditions for 
the same, relatively short, period of time regardless of when they entered the chamber 
during the 40 minute specimen processing time. Passage of cells through this zone took 
about 180 seconds. This afforded sufficient time for the cells to sediment to equilibrium 
positions close to the chamber floor so that they entered the DEP equilibration zone at 
identical heights and all were subjected to similar electric field conditions. Altogether, 
depending on their type cells spent between 220 and 600 seconds in the DEP-FFF 
chamber from injection to withdrawal, well below the 1000 seconds at which dielectric 
alterations due to exposure to low ionic strength media become apparent. 
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5.2.4 DEP-FFF microelectrode stage 
 
The frequency and magnitude of the electrical signal applied to the 
microelectrodes in the DEP equilibration zone (Figure 5.1 (d)) were chosen so that the 
tumor cells were pulled towards the chamber floor while the PBMNs were repelled high 
above it. In Chapter 3, the crossover frequencies of all cell types derived from solid 
tumors in the widely representative NCI-60 panel of cancers were shown to lie far below 
those of all the subpopulations of peripheral blood cells.  By choosing a DEP signal 
frequency that was between the crossover frequencies of tumor cells and the PBMNs, it 
was possible to impose differential DEP forces to drive cell separation and allow the 
tumor cells to be isolated by skimming them from the chamber floor.  At the target 
equilibrium eluate conductivity of 60 mS.m-1 used for my continuous flow DEP-FFF 
tumor cell isolation experiments, the crossover frequencies of  of all solid tumor cell 
types were well below 100 kHz while those of all the blood cell subpopulations were 
above 200 kHz.  A DEP signal frequency of 130 kHz was chosen, therefore, for my 
tumor cell isolation experiments. (Recall that the crossover frequency is proportional to 
the cell medium suspension conductivity (Equation 1.11), so that the of  values 
measured by batch mode DEP-FFF at 30 mS.m-1 in the prior chapters expected to be half 
the corresponding of values at the 60 mS.m
-1 target conductivity value used for my 
continuous flow DEP-FFF isolations).   
The DEP force imposed on the cells depends on the square of the applied voltage 
V (Equation 1.1), suggesting it might be advantageous to use a high DEP voltage to 
increase the height differential between tumor and PBMNs leaving the DEP equilibration 
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zone[93].  However, the electric field that gives rise to the DEP force also induces a 
transmembrane potential difference in the cells that can stress them and cause them to 
become leaky towards ions and/or electroporated. This could alter their DEP properties 
and confound their separation characteristics. The magnitude of the induced 
transmembrane potential difference depends upon the electric field strength, the cell 
diameter and the applied electric field frequency[103]. Because of their larger diameter 
and closer proximity to the microelectrodes during continuous DEP-FFF isolation, tumor 
cells are more prone than PBMNs to damage by high voltage in DEP-FFF cell isolation 
experiments.  However, I found that I could use an applied voltage of 4V p-p in the 
experiments to provide strong DEP forces without evidence of diminished tumor cell 
isolation efficiency. Catalase was included in my eluate buffer as in my previous 
work[24, 95] to protect the cells from a low concentration of reactive oxygen 
intermediates that may be produced by electrochemical processes at the 
microelectrodes[103]. 
To confirm the differential height distributions of tumor cells and PBMNs under 
conditions chosen for continuous flow DEP-FFF, I ran a batch-mode DEP-FFF 
experiment and recorded the time-dependent elution profile of a mixture of PBMNs from 
healthy donors and MDA-MB-231 human breast cancer cells.  As in Chapter 2, the cell 
elution times were mapped to the cell equilibrium height distribution in the chamber, 
which is shown in Figure 5.4. It may be seen that the MDA-MB-231 cells traveled 
through the DEP-FFF chamber between 5 and 13 μm above the chamber floor while the 
PBMNs were transported at between 14 and >40 μm height.     
In Figure 5.4, the batch mode DEP-FFF chamber had a microelectrode array area 
of 7500 mm2 and the power output capacity of the signal generator limited the maximum 
DEP voltage that could be applied to it to 2.8 V p-p.  In my continuous flow DEP-FFF 
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design, however, I shortened the microelectrode array to only one third the length of the 
batch mode chamber. This shorter array drew only 1/3 of the DEP current and permitted 
me to use a higher DEP operating voltage of 4 V p-p.  Under these conditions, the 
levitation height for PBMNs was  > 27 μm. Accordingly, I chose a skimming height of 
hs=26 μm by setting the withdrawal rate to qout=20 μL.min-1 for continuous flow DEP-
FFF cell isolation experiments (as in Figure 5.2(a)).  In this case, the specimen injection 
and outlet withdrawal rates were the same.  
 
 
Figure 5.4 Height distributions of MDA-MB-231 human breast cancer cells and 
PBMNs in batch mode DEP-FFF separation. The height distribution was 
mapped from the cell elution times assuming that the transit velocities of the 
cells reflected their heights in the Poiseuille hydrodynamic flow profile 
inside the DEP-FFF chamber. 
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5.3 TESTS AND CLINICAL RESULTS 
 
The final design of my continuous flow DEP-FFF device used for cell spiking 
tests and CTC isolation employed a chamber 160 mm long with a width of 25 mm, a 
height of 314 μm, and an inlet to outlet slot spacing of 90 mm. The chamber floor was 
lined by a microelectrode array based on the design detailed earlier[104] in which parallel 
gold-on-copper microelectrodes of 50 μm width and spacing were patterned on a kaptan 
substrate.  However, only the last 45 mm of the microelectrode array leading up to the 
outlet slot was energized.  The DEP and flow conditions were as described in the 
optimized simulations in the earlier figures with eluate flow rate= 2000 μL.min-1, 
specimen injection flow rate=20 μL.min-1 and CTC skimming flow rate= 20 μL.min-1. A 
continuous sinusoidal DEP signal of 130 kHz at 4 Vp-p was employed, and the 




Figure 5.5 (A) Chamber floor of the final continuous flow DEP-FFF design showing 
the laser cut inlet and outlet slots for injecting the specimen and skimming 
off the cancer cells and the DEP microelectrode array with dimensions. (B) 
The continuous flow DEP-FFF isolator with the chamber top in place. 
 
I ran tests of the continuous flow DEP-FFF isolator design using MDA-MB-435, 
MDA-MB-231 and other cultured tumor cells spiked into PBMNs from healthy donors to 
compare with my earlier batch-mode DEP-FFF experiments[95].  During these tests, the 
chamber was mounted on the stage of a Mitotoyo long working distance microscope so 
that the injection and skimming behavior of the cells could be observed.  Recovery rates 
of 70% to 80% were found for the cancer cells. Unfortunately, the laser cut slots were 
imperfect and it was apparent that the injection and skimming flows were not consistent 
over the entire widths of the slots. These imperfections seemed to arise because the slot 
 117
edges were slightly irregular. In addition, the electrode substrate of 35 µm thick Kapton, 
which was glued down with double sided adhesive tape to form a carpet on the floor of 
the chamber was not perfectly flat.  These two issues clearly perturbed the flow patterns 
in the chamber and resulted in variations of injection and skimming heights across the 
slots. This could clearly be observed to lower the efficiency of the DEP-FFF recovery of 
the cancer cells spiked into PBMNs because these cancer cells could be seen to 
consistently “jump the gap” in some parts of the withdrawal slot. It is not clear by how 
much this lowered the collection efficiency of the continuous DEP-FFF but it seems 
reasonable to speculate that a chamber with improved physical characteristics might 
approach the 90% efficiency level reported earlier for cancer cell recovery from PBMNs 
by batch mode DEP-FFF.  These chamber problems are being addressed by having a 
new microelectrode electrode with precision laser-cut slots fabricated commercially on 
150 µm thick substrate that should lie flat in the chamber. 
Even with these shortcomings, my measurements confirmed that tumor cell 
isolation efficiencies of 70- 80% were achieved consistently and independently of the cell 
spiking density.  To illustrate this, MDA-MB-435 cells were prelabeled with fluorescent 
dye (CellTracker Green CMFDA, Life Technologies, Grand Island, New York) and 
spiked into PBMNs from 10 mL blood specimens at concentrations ranging from 50 to 
600 per mL. The output port of the DEP-FFF chamber was connected to a modified flow 
cytometer[98] so that labeled tumor cells could be gated and counted by their 
fluorescence (Ex 488 nm, Em 517 nm) as they emerged and discriminated from 
contaminating blood cells. Figure 5.6 shows the cytometric scatter plots obtained at three 
different spiking concentrations. Even with the imperfections in the DEP-FFF chamber 
floor already noted, the average collection efficiency was found to be 75% and 
independent of spiking density. Given that the concentration of cells in these isolation 
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experiments is well below that at which cell-cell interactions would be expected to affect 
separation behavior in continuous flow DEP-FFF, this independence of performance on 




Figure 5.6 Flow cytometric (FACS) scattergrams showing the recovery of tumor cells 
from PBMNs spiked with (a) 6000, (b) 2000 and (c) 500 MDA-MB-435 
cultured cells prelabeled with CellTracker Green fluorescent dye. 
 
Despite these encouraging results using spiked samples, I was made aware by Dr. 
Apostolia Tsimberidou, who provided me with clinical specimens (see later), that the 
dielectric properties of the blood of cancer patients might be modified by their disease 
and treatment regimen, compared with the blood of healthy donors.  For example, 
leukocytosis, thrombocytosis and increased acute phase protein levels in the blood are 
typically part of a chronic systemic inflammatory response to late stage malignancy[105]. 
These factors have the potential to lead to anomalous blood cell subpopulations that 
might contaminate CTCs during DEP-FFF isolation.  Therefore, I conducted a 
preliminary trial using twenty clinical specimens from late stage cancer patients to 
establish whether CTCs could be isolated from blood under realistic clinical conditions.  
Peripheral blood specimens were obtained as part of the Initiative for Molecular Profiling 
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in Advanced Cancer Therapy (IMPACT) Trial at The University of Texas M.D. 
Anderson Cancer Center with informed patient consent and the approval of Institutional 
Biosafety Committee.  Specimens of at least 7 mL volume were collected from patients 
in 10 mL BD purple cap (EDTA) vacutainers and processed within 3 hours.  The 
PBMNs, putatively containing CTCs, were separated from the patient specimens over 
Histopaque 1077 and subjected to continuous DEP-FFF also using same settings as for 
the spiked PBMN specimens.  In this case, the isolate from the withdrawal slot was 
collected in a 1 mL syringe for each specimen over the approximately 40 minute 
processing period.   
The FACS approach was not feasible for analyzing CTCs isolated from clinical 
specimens because the 10 mL blood specimens may have contained as few as ten, and 
very rarely more than hundreds of, CTCs. Downstream immunostaining of the collected 
cells followed by subsequent FACS analysis would not have allowed such small cell 
populations accurately. Therefore, a CytoproTM instrument (Wescor Model 7620, Logan, 
Utah) was used to mount the cells from the clinical blood isolates onto two microscope 
slides.  One slide was immunostained for cytokeratin using FITC-conjugated CK3-6H5 
antibodies (Miltenyi Biotec, Bergisch Gladbach, Germany) combined with nuclear 
staining by DAPI (D1306 Molecular Probes, Eugene, Oregon).  An example of a slide 
stained this way is shown in Figure 5.7, where putative CTCs show green fluorescence 
due to the presence of cytokeratin and both CTC and PBMN nuclei exhibit blue 
fluorescence.  The slide is suggested to show putative CTCs, since most blood cells do 
not express cytokeratin. 
Although it is common practice in the literature to assume that the cells which 
express cytokeratin that are isolated from the peripheral blood of cancer patients are 
CTCs, irrefutable validation of their tumor origin requires that they are demonstrated to 
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carry the same genetic lesions that are characteristic of the patient’s primary tumor.  
Fortunately, the primary tumors of all patients enrolled in the IMPACT trial (the human 
specimens used in this experiment were collected under IRB approved protocols and 
provided to me without patient information or identities. IRB approval protocol number: 
LAB07-0817, full Title:  Blood, Bone Marrow and Tissue Collection for Patients with 
Advanced Malignancies seen in the Clinical Center for Targeted Therapies, study Chair: 
Apostolia M. Tsimberidou, M.D. University of Texas M.D Anderson Cancer Center) are 
subjected to screening for somatic mutations. In order to verify the presence of CTCs in 
my isolates, definitively, the unstained slides were therefore given for molecular analysis 
to Dr. Katherine Stemke Hale of the Kleberg Center for Molecular Pathways at M.D. 
Anderson.  DNA was extracted from the slides using PicoPure (cat 11815-00, Applied 
Biosystems) then further cleaned with a QIAamp DNA Micro Kit (cat 56304, Qiagen). 
 
 
Figure 5.7 Circulating tumor cells collected by continuous flow DEP-FFF from the 
peripheral blood of a patient with colon cancer. The green fluorescence 
reveals staining of cytokeratin in the tumor cells by FITC-conjugated CK3-
6H5 antibodies.  PBMNs show only blue fluorescence due to DAPI 
staining of their nuclei. 
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The DNA was preamplified using the following primers:  
Forward:   ATGACTGAATATAAACTTGTGGTAGTTGGA  
Reverse:   GAATTAGCTGTATCGTCAAGGCACT  
Vic Reporter:  CTTGCCTACGCCACCAG  
FAM Reporter:  CTTGCCTACGTCACCAG  
 
The Taqman Pre-Amp Master Mix (Cat 4391128) was employed according to the 
protocol specified by Fluidigm.  Sample from my slides, together with a positive and a 
negative control, were tested using a Fluidigm 48.48 Genotyping Array (cat BMK-M-
48.48GT, Fluidigm) according to Fluidigm’s protocol.  For the colon cancer specimen 
shown in Figure 5.7, the somatic mutation in the primary tumor was KRAS G13D.  
MDA-MB-231 was used as a positive control for this because it possesses the same 
mutation. The slide specimen exhibited a positive result with a signal intensity that 
indicated approximately 10% of the cells on the slide had the KRAS G13D mutation, 
mirroring the proportion of cells that stained positively for cytokeratin in Figure 5.7. This 
not only verified that sufficient CTCs were present on the slide to identify the cancer-
causing gene but also shows that the continuous flow DEP-FFF method coupled with 
molecular analysis may be suitable for clinical screening purposes.  
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CHAPTER 6 CONCLUSIONS AND FUTURE PERSPECTIVES 
 
This dissertation describes the work I undertook to test the hypothesis that DEP-
FFF principles could be adapted to a continuous-flow regime that would allow 10 mL 
clinical specimens to be processed in less than 60 minutes and thereby provide a 
universal and reliable detection method for CTCs that was independent of cancer type 
and surface markers. A number of steps were needed to accomplish this involving both 
biophysical and engineering challenges. The biophysical aspects involved establishing 
whether cell dielectric properties, which earlier work had found to reflect the state of cell 
transformation, would enable the isolation of cancer cells from the subpopulations of 
peripheral blood cells not just in special cases but generally for all cancers. To achieve 
this, it was important not only to examine a wide variety of tumor cell types and compare 
their properties to those of blood cells but also to attempt to understand the biological 
basis for any observed differences.   
Prior work in the characterization of cell dielectric properties had relied on single 
cell dielectric crossover and electrorotation techniques. In these methods, the dielectric 
properties are examined one cell at a time, taking several minutes per cell. Although the 
dielectric properties of a number of cell lines have been reported using these methods, 
they are so tedious that most publications reported measurements on only 10 to 20 
individual cells of each type. The resulting data provided estimates of the statistical 
distributions of the different cell types but there was insufficient data to be able to infer 
whether cell subpopulations were present.  I considered this data insufficient and the 
tedious approached inadequate to undertake a robust study of cell dielectric properties in 
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the context of designing a reliable cell isolator for CTCs. Therefore, in Chapter 2, I 
developed a profiling technique that allowed cell density, deformability and DEP 
crossover frequency to be inferred from DEP-FFF elution profiles. These new profiling 
techniques allowed me to undertake measurements on the entire NCI-60 panel of cells 
types as well as on many other cell lines that were available to me. Data was obtained for 
an unprecedented number of cells types with unprecedented detail. Thus, I showed in 
Chapter 3 that all of the NCI-60 cell types had DEP crossover frequencies that allowed 
them to be discriminated from blood cells. Furthermore, the statistical distributions of the 
DEP crossover frequencies of all of the cell types that had been derived from solid 
tumors in the NCI-60 panel were widely separated from those of the cell types in 
peripheral blood, showing that DEP-FFF should be able to isolate the cancer cells from 
blood with high efficiency. Leukemia–derived cell types also had significantly different 
DEP crossover frequencies from the blood subpopulations but the statistical distributions 
were not widely separated, showing that DEP-FFF is suited for concentrating leukemia 
cells from blood but not for isolating them into pure fractions. The discovery that all of 
the solid tumor types in the NCI-60 panel, spanning the clinical diversity of 9 organ 
types, had such different DEP properties from blood cells lent support to the concept that 
DEP-FFF isolation might be very broadly applicable to different cancer types. 
Furthermore, the result that the DEP-FFF isolation was “blind” to differences in cell 
surface receptors and ligands confirmed the advantages of DEP-FFF over antibody-based 
methods which have the prerequisite that target cells possess specific antigens.  My 
results, therefore, confirmed that DEP-FFF is an antigen-independent cell isolation 
methodology. Nevertheless, to demonstrate that DEP should be applicable to all cancers, 
I felt it was important to understand the biological basis for the DEP crossover frequency 
differences and to show that these were general for cancer. 
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The diversity of cell types in the NCI-60 panel allowed me to examine 
correlations between cell characteristics and DEP properties in Chapter 4. Given that 
prior work had established that DEP crossover frequencies depended on cell membrane 
morphology, I focused on factors that could lead to differences in membrane morphology 
when cells were released from their growth sites into suspension. Although previous 
work had shown that DEP properties and cell membrane morphologies were linked, it 
had not sought to understand the reasons for the differences in membrane morphology of 
cells in suspension. By observing that cells growing in juxtaposition had a morphology 
adapted to cell-cell contact and adhesion, I realized that cells in tissue have surface area 
to volume characteristics that are quite different from those in free suspension. By 
proposing that cell membrane area and volume were conserved when cells detached from 
their growth site, I was able to derive formal relationships between the morphology of a 
cell prior to detachment, its membrane morphology after detachment, and its DEP 
crossover frequency properties in suspension. I showed that a morphological parameter 
for the growing cells correlated well with cell DEP crossover results in suspension.  It 
seems to be reasonable to conclude from these results that CTCs released into suspension 
from any type of solid tumor should have characteristics that allow them to be captured 
from blood by DEP-FFF. Nevertheless, this morphology argument should apply to all 
cells that are released from solid tissue into the blood circulation, whether they are 
cancerous or not. Thus, cells collected from peripheral blood by DEP-FFF cannot 
necessarily be assumed to be cancer cells. Nevertheless, this is no different from other 
CTC collection methods. For example, while it is often assumed in the literature that 
EpCam+/Cytokeratin+/CD45- cells detected by the CellSearch method are CTCs, this may 
not be true. It is quite likely that normal cells are shed into the peripheral blood as the 
result of non-cancerous pathologies, even if these are rare. It follows that some type of 
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verification is always required as an adjunct to cell isolation to verify that putatative 
CTCs are of tumor origin. 
In Chapter 4, the membrane area of cells was also shown to bear a fractal 
relationship to cell radius. This demonstrates that conventional wisdom that cell size is 
limited by cell membrane area according to a square-law radius relationship is incorrect. 
Evidently cell structure-function relationships are more complex than that and the cell 
molecular apparatus includes the capacity to increase cell membrane area to meet 
transport needs. Interestingly, after being released from their growth sites and maintained 
in suspension out of contact with adherent surfaces, the conserved cell volume and 
membrane area began to adapt by a process of cytoplasmic shedding.  This process did 
not indicate that programmed cell death through anoikis or apoptosis had been initiated, 
however, because the shedding cells could still be returned to normal adherent culture 
and grown.  Rather, the cytoplasmic shedding appears to be part of a cell remodeling 
process that involves non muscle myosin (NMM) through active physiological processes. 
The presence of pleomorphism in the CTC populations captured by a number of isolation 
methods including CellSearch and high throughput flow cytometry as well as in ovarian 
cells that I isolated from ascetic fluid suggests that a similar process of cell shedding 
likely occurs after tumor cells have been released from their primary tumors into the 
peripheral blood.  The shedding process may help explain how CTCs, which are 
normally thought of as being large, are able to pass through, and create metastases within, 
fine capillaries in organs, including the brain and the lungs, and in the periphery of the 
body.  
Even though cancer cells shed membrane and cytoplasm over a period of hours 
when placed in suspension, I showed that the total membrane capacitance of these cells 
remained significantly higher than that of blood cells, even when the shedding was so 
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extreme that the radius of the cancer cells had fallen to within the range of blood cell 
radii. This finding is significant because it shows that DEP-FFF can be used to isolate 
CTCs of all sizes. This distinguishes the method from other antibody-independent CTC 
isolation techniques including size-based filtering and hydrodynamic inertial filtering for 
which cell size and consistent flexibility are fundamental parameters underlying the 
respective isolation phenomena. 
It is frequently argued that the behavior of cells grown in culture may not reflect 
the properties and behavior of cells in vivo. This argument seems especially valid when 
comparing the behavior of cells that have been immortalized and grown in a monolayer 
culture with normal, mortal cells that are growing within a living organ. In my work, 
however, most of the cultured cells I used were not immortalized by treatment with virus 
or other agents and owed their growth capabilities in culture to the oncogenes that led 
them to be cancers in the patients from whom they were donated when the cell lines were 
first established. Furthermore, my studies were aimed at understanding the behavior of 
the tumor cells after they were released from growth sites and placed in suspension, often 
with blood or PBMNs.  These conditions seem to a great extent to mirror the origin of 
CTCs in peripheral blood. Therefore, while there is still the need for caution and the 
recognition that my cell models are not the same as clinical specimens, there seems to be 
a reasonably high likelihood that the behaviors I observed for 60 independent cultured 
specimens from different origins mimic, at least broadly, the behaviors of real CTCs.   
Having understood the parameter requirements for efficiently isolating the wide 
range of cancer cell types in the NCI-60 panel and discovered the surprising result that a 
single set of DEP-FFF isolation parameters would be applicable to the isolation of CTCs 
from any type of solid tumor, I designed and built a continuous-flow DEP-FFF isolator.  
Chapter 5 describes the technical principles involved in this effort and shows my final 
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working design, which had to solve several engineering challenges. First, the cells in the 
specimen needed to be maintained in their physiological medium until just prior to DEP-
FFF processing at which time their suspending medium conductivity needed to be greatly 
lowered while their osmolarity was maintained. In addition, the cells needed to be close 
to the chamber floor by the time they encountered the DEP-FFF microelectrode array.  
These problems were solved by developing a π-shaped chamber through which a carrier 
eluate was flowed.  Cells were injected through a slot in the chamber floor into a thin 
lamina that flowed beneath the eluate. Cells in this thin lamina had very little distance to 
settle to the chamber floor and their conductivity and osmolarity was adjusted by passive 
diffusion of ions and sucrose across the interface of the specimen lamina and the eluate 
flow through a process we termed membraneless dialysis.  Once the conductivity had 
been lowered, the CTCs and blood cells were spatially separated by dielectrophoresis. 
The DEP frequency was chosen so that cancer cells were pulled gently to the 
microelectrode array on the chamber floor by positive DEP (much less force than was 
needed to trap them) and the CTCs were repelled 25 µm or more above the chamber floor 
by strong negative DEP. Cancer cells were then skimmed off by a low flow through an 
exit slot.  Using this design, I demonstrate the isolation of tumor cell spiked into normal 
peripheral blood with an efficiency of 70-80%. The slot and electrode design showed 
physical irregularities that clearly impacted the isolation efficiency and it is likely that an 
efficiency around 90% is achievable because would be consistent with the efficiency 
observed in small batches of cells by batch-mode DEP-FFF.  
I applied the continuous flow DEP-FFF to several clinical specimens and showed 
that CTCs could be isolated from all of them. In two examples where the CTCs exhibited 
somatic mutations for which the Kleberg Center for Molecular Pathways was able to 
conduct analysis of my isolates, the mutations were detected at levels that were consistent 
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with the proportion of cytokeratin-positive cells that visible through immunolabeling. 
These data showed that my continuous-flow DEP-FFF isolator worked for clinical 
specimens.   
Several areas for further development are clear. First, head-to-head comparison 
between DEP-FFF and other CTC isolation methods is needed.  It appears that with 
improved electrodes and slots we might achieve 90% isolation efficiency of CTCs.  The 
published CellSearch efficiency data has statistical complications because the authors of 
the studies insist that the correct way to test a CTC isolation method by spiking 
experiments is to place 1 CTC into 10 mL blood and then to demonstrate that one can 
recover that single cell.  This approach has no statistical validity. By adding many CTCs 
to blood, we show that our recovery rate by batch mode DEP-FFF is ~90%. At one 
conference my approach was criticized by a Johnson and Johnson representative as being 
inferior to the CellSearch method which could successfully recover a single cell seeded 
into 10 mL blood.  My recovery efficiency suggests that if I did multiple experiments 
each with 1 cancer cell seeded into blood then I would, on average, recover that single 
cell on nine out of ten occasions.  But as long as clinicians can be swayed by such 
obfuscation by vendors, there will be a serious problem in comparing technologies in the 
CTC field.  
Another important issue that I did not have time to address was the purity of the 
CTC specimens I collected. With the DEP-FFF settings I used, several thousand blood 
cells were captured in the outlet slot together with the cancer cells. These contaminating 
cells had morphological characteristics that suggested they were approaching the end of 
their life in the peripheral blood and were dying. If blood cells suffer erosion of their 
membrane barrier function, as is expected towards the end of their lifetimes, then they 
would no longer fulfill the criteria for DEP attraction or repulsion delineated in Chapter 
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1.  Instead, they would flow over the DEP-FFF microelectrode without experiencing any 
significant DEP forces at all. With the chamber configuration I used for continuous flow 
DEP-FFF, these cells would simply drop down the outlet slot used to skim off the cancer 
cells and therefore they would end up contaminating the target cells, as I observed. This 
problem was especially significant in a few of the late-stage patient specimens I 
examined. As mentioned in Chapter 5, Dr. Tsimberidou warned me that the dielectric 
properties of blood cells might be modified in late stage cancer patients. Although I 
found that the majority of the PBMNs in cancer patients behaved in the same way as 
those from normal blood donors, the PBMNs were highly reactive, tended to be adherent, 
and the captured cell fractions from these cancer specimens were found to be 
contaminated with many thousands of blood cells. This suggested that those specimens 
contained a higher proportion of damaged PBMNs that fell down the outlet slot along 
with captured CTCs. This apparently serious problem should be easy to solve, however, 
because very large dielectric differences can be anticipated between captured cancer cells 
and damaged blood cells. Specifically, this problem should be easily addressable by 
incorporation of an additional DEP stage at the outlet that would remove the 
contaminating, damaged blood cells from the target CTCs, leaving the CTCs in a much 
higher state of purity. 
Another aspect worthy of future work are molecular studies of isolated cells. 
CTCs carry genetic information about the primary tumor and, in addition, possess (as yet 
unidentified) molecular signatures that are indicative of their metastatic potential. One 
such genetic trait may be the ability to maintain viability during shedding, as discussed in 
Chapter 4. Other potentially dangerous traits include their degree of stem characteristics, 
which is considered to be indicative of the flexibility the CTC will show in adapting to a 
new site and growing vigorously. In my studies, putative CTCs were pooled from slides 
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for genetic analysis and these tests verified the applicability of DEP-FFF isolation as a 
front end for molecular analysis. Newer molecular analysis instruments are becoming 
available that can analyze the molecular profile of single cells on slide. This shows that it 
should soon be possible to investigate the heterogeneity of molecular profiles of CTCs 
and this should give additional insights into the danger posed by specific CTCs.  These 
results would be applicable to prognosis and potentially to diagnosis and targeted therapy 
matching. 
During my studies, the DEP-FFF methods were licensed by The University of 
Texas M.D. Anderson Cancer Center to ApoCell, Inc., and considerable efforts were 
made to transfer all knowledge to the company to enable the development of a 
commercial version of the continuous-flow DEP-FFF isolator. These efforts were 
successful and ApoCell is now commercializing the technology with 10 prototypes.   
ApoCell sponsored aspects of the research in the lab to aid in this commercialization 
effort and promised to make my lab a test center for the commercial version. However, 
once the commercial version was developed, ApoCell refused to follow through with a 
second phase sponsored research agreement and placed commercial instruments in 
another lab at MD Anderson and at other cancer centers around the US without telling us. 
Furthermore, ApoCell reproduced several of the experiments that I conducted in this 
work and for which I had shared proof of concepts and data. Apocell [106]then published 
a paper including these findings without telling us or including me or my advisor as 
authors. M.D. Anderson counsel declined to take action in any of these matters. 
Fortunately, I have since published three comprehensive articles that go far beyond the 
work ApoCell could publish to establish that these studies were from our laboratory.  
Sadly, several lines of studies that ApoCell had suggested and then decided not to support 
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had to be stopped and Mr Tom Anderson, who assisted in the fabrication of all my 
devices, lost his position 
Despite these setbacks, I was able to achieve every aim of my research and 
largely demonstrate my hypothesis. Its final proof will lay ahead as ApoCell and others 
attempt to use the concepts introduced here in clinical applications. If the methods 
become clinically applicable and impact metastatic cancer in the future then I will feel 
fulfilled in all my efforts. 
 
 132
Appendix A Cell throughput consideration 
 
Jones showed that cells begin to experience dipole-dipole interactions that can 
affect their DEP behavior when they are less than about 5 diameters apart[44].  To 
ensure that the DEP-FFF properties are controlled by the intrinsic properties of the cells 
and are not impacted by such interactions, the cell concentration, “loading 
concentration”, therefore needs to be low enough to achieve adequate separation. In batch 
mode, the front end of a DEP-FFF chamber of height H  is filled with a particle 
concentration N  m-3. After settling into a 2-D layer on the floor of the DEP-FFF 
chamber, the mean cell spacing will be  
 
( ) 21−= HNS     (A.1) 
 
In order for S to be at least 5 cells diameters, the maximum concentration in the cell 
mixture must be  
 
( ) 12max 25 −= HdN c    (A.2) 
 
where dc=cell diameter. 
If the cells are of 10 µm diameter then 610~N  cells per mL. further, if the 
DEP-FFF chamber has a volume of 5 mL and the chamber is filled to 10% of its total 
length, then a maximum of 5 x 105 cells can be processed per batch to satisfy the spacing 
requirement.  If the turnaround time is 15 minutes per batch then this sets the maximum 
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throughput rate at around 2 x 106 cells per hour. This is not a problem for analytical 
applications but it is about 20 times slower than is needed for isolating CTCs from 10 mL 
clinical specimens. 
The same cell spacing criterion applies in continuous flow DEP-FFF but, in this 
case, the cell suspension is injected only up to a height h , so that the maximum 
concentration can be 
 
( ) 12max 25 −= hdN c     (A.3) 
 
For a cell injection rate of 25µL.min-1, an eluate flow rate of 1000µL.min-1, and a 
chamber height H  of 580µm, Eqn 5.2 (Chapter 5) shows that the height of the chamber 
filled with cells h  = 53 µm.  To achieve a particle spacing of at least 5 diameters, the 
maximum concentration is 6106.7~ ×N  cells of 10µm diameter per mL.  At the given 
injection rate, this corresponds to a throughput of 7.6x106 cells per minute, or 4.5 x 108 
cells per hour. This allowed me to process sufficiently 10 mL clinical blood specimens, 
which contained ~ 4 x 107 total PBMNs, in 40 minutes.  
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Appendix B Analysis of parameter sensitivity 
 
In designing the DEP-FFF instruments for cell analysis and CTC isolation, it is 
important to specify the accuracy with which the system parameters must be controlled in 
order to achieve a desired accuracy in cell parameters or efficiency of cell isolation.   
To achieve this, a sensitivity analysis is required to show how performance parameters 
depend on system parameters. In this section, the sensitivities are calculated for each 
operational parameter using the method of differential calculus. The equations for DEP-
FFF system operations have been derived in Chapters 1, 2 and 5. For characterizing cells, 
the cell properties in batch-mode DEP-FFF affect the heights at which they are 
transported through the chamber, effectively mapping cell physical properties to elution 
time profiles.  
The flow velocity at height h in a chamber of height H  and width W for a flow 
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The time taken for a particle at height h to be eluted from a chamber of  length L will be  
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Sensitivity of T versus small changes in H 
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This shows that a 1% change in chamber height will lead to a 2% change in 
elution time.   
 



















This shows that a 1% change in particle height will lead to a 1% change in elution 
time.   
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This shows that a 1% change in chamber width will lead to a 1% change in 
elution time.   
 
 
Sensitivity of T versus small changes in applied voltage V 
 
At low frequencies, cells are levitated and the hydrodynamic lift force can be 
ignored\ 
 
0=+ SEDDEP FF      (B.11) 
 
This can be expressed as 
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Combining (A.12) and (A.13), we obtain 
 











ρ  . (B.14) 
 
Taking natural logarithms and differentiating gives us 
 
V
Vhh ∂=∂ 02  .    (B.15) 








∂ 02     (B.16) 
 
For the electrodes used in my studies, the characteristic height mh μ50 ≈ . 
This sensitivity equation shows that the sensitivity of elution time to changes in 
voltage depends very sensitively on the height of the cells in the chamber, and becomes 
very high as the height approaches zero. In practice, the lowest attainable height is the 
cell radius.  Although the applied voltage from the signal generator is easy to control to 
high accuracy, it is important to note that the effective voltage in DEP-FFF experiments 
depends on voltage drops in the circuit and upon electrode polarization, which can 
change with the condition of the electrode metal during use. Careful monitoring of V and 
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the electrode condition is therefore required when the cells under study travel through the 
DEP-FFF chamber at small heights.  
At larger heights, 0hh >> , the sensitivity of the elution time to small changes in 
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